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Mitochondrial dynamics, including fusion and fission, are vital for supplying cellular 
energy as well as controlling other tasks including apoptosis, aging and cellular 
differentiation. Defects of mitochondrial fission pathway have been implicated in a 
wide spectrum of human diseases such as Parkinson’s disease and Alzheimer’s 
disease. Although recent findings point to a role of the actin cytoskeleton in 
regulating mitochondrial division, little is known about the mechanism. Here, I report 
that transient de novo polymerization of F-actin on the outer mitochondrial membrane 
contributes to Drp1-dependent mitochondrial division in mammalian cells. Transient 
de novo F-actin assembly on the mitochondria occurs upon induction of 
mitochondrial fission and F-actin accumulates on the mitochondria without forming 
detectable submitochondrial foci. Impairing mitochondrial division through Drp1 
  
knockout or inhibition prolonged the time of mitochondrial accumulation of F-actin 
and also led to abnormal mitochondrial accumulation of the actin regulatory factors 
cortactin, cofilin, and Arp2/3 complex, suggesting that disassembly of mitochondrial 
F-actin depends on Drp1 activity. Furthermore, downregulation of actin regulatory 
proteins Arp2/3 complex, cortactin and cofilin led to abnormal elongation of 
mitochondria, associated with mitochondrial accumulation of Drp1. In addition, 
depletion of cortactin inhibited Mfn2 downregulation- or FCCP- induced 
mitochondrial fragmentation. These data indicate that the dynamic assembly and 
disassembly of F-actin on the mitochondria participates in Drp1-mediated 
mitochondrial fission. Moreover, I also discovered a novel F-actin involved 
mechanism of mitochondrial fission regulated by deubiquitinase Usp30. 
Overexpression of Usp30CS predicted to lack deubiquitinase activity induced 
abnormal elongation and thinning of mitochondrial tubules. Furthermore, expression 
of Usp30CS preferably binds to Drp1, inducing a dramatic redistribution of Drp1 from 
the cytosol to the mitochondria, and accumulation of high molecular weight Drp1 
species. Importantly, FCCP induced a gradual tubulation of Drp1-containing 
structures, accompanied with mitochondrial associated F-actin in a similar timeframe 
in Usp30CS-expressing cells, suggesting that inhibition of Usp30 deubiquitnase 
activity stalls progression of Drp1-dependent mitochondrial division.  In sum, here I 
report that mitochondrial F-actin polymerization is a required step of mitochondrial 
fission, regulated by actin-modifying proteins and deubiquitinase Usp30, providing 
in-depth vision and a novel mechanism of actin cytoskeleton participated 
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Chapter 1: General Introduction 
 
Section 1: Structural and functional complexity of the mitochondria 
Mitochondria are essential organelles providing energy in a form of ATP to 
support cell metabolism and cellular homeostasis.  Mitochondria are a unique among 
other cellular organelles due to their double membrane structure, consisting of an 
inner mitochondrial membrane (IMM) and outer mitochondrial membrane (OMM). 
The OMM separates mitochondria from the cytosol with a similar protein-to-
phospholipid ratio to plasma membrane. The OMM is permeable to a wide range of 
small molecules including ions, adenosine triphosphate (ATP) and nutrient chemicals. 
Translocase of outer membrane (TOM) forms a complex on the OMM and acts as a 
transport channel to allow proteins synthesized in the cytosol to be imported into the 
mitochondria (Dietmeier et al. 1997). The IMM is extensively folded and 
compartmentalized to form mitochondrial cristae, which provides a large surface area 
that is mostly occupied by oxidative phosphorylation (OXPHOS) complexes. The 
IMM encircles mitochondrial matrix, a mitochondrial compartment, containing 
soluble enzymes, mitochondrial DNA (mtDNA) and mitochondrial ribosomes. 
Mitochondrial cristae are the major location for proteins mediating ATP synthesis and 
controlling cellular oxygen consumption, including five multisubunit OXPHOS 
complexes (Gilkerson et al. 2003). Electrons are transferred from electron donors to 
electron receptors through redox reactions in complex I-IV to generate chemical 
proton gradient between inter-membrane space and matrix. Complex V, also known 
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as F0/F1 ATP-synthase synthesizes ATP through oxidative phosphorylation using the 
chemiosmotic proton gradient generated by electron flow through complexes I-IV 
(van den Heuvel & Smeitink 2001).  
Mitochondrial DNA (mtDNA) also locates in the mitochondrial matrix. 
Unlike nuclear DNA packaged as chromatin, mtDNA is circular. It contains 37 genes 
that encode critical subunits of the OXPHOS system. The process of mtDNA 
replication is mediated by DNA polymerase gamma complex encoded by the POLG 
gene, the twinkle DNA helicase and single-stranded DNA-binding protein via two 
competing mtDNA replication models (1) the strand-displacement mode (2) the 
strand-coupled mode (Park & Larsson 2011). mtDNA has a 10-17 higher mutation 
rate than nuclear DNA, which is possibly due to the mitochondrial levels of free 
dNTP and reactive oxygen species (ROS). ROS are produced during cell metabolism 
as a by-product of electron transfer through the electron transport chain. This leads to 
two major mutagenic changes in mtDNA through the formation of 8-oxo-2’-
deosyguanosine and single/double strand breaks. Mutations of mtDNA, and resulting 
OXPHOS defects, are closely linked to aging, apoptosis and numerous other 
pathologies (Tuppen et al. 2010).  
In addition to energy generation, mitochondria also serve as a signaling 
platform critical for intrinsic apoptotic pathway initiation by a wide range of 
intracellular perturbations such as DNA damage and oxidative stress. When pro-death 
signals prevail, translocation of pro-apoptotic multi-BH-domain proteins to OMM 
originates mitochondrial outer membrane permeabilization (MOMP) through 
Bax/Bak dependent pore-forming activity, leading to the release of potential toxic 
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proteins such as cytochrome c and apoptosis inducing factor (AIF) into cytosol. The 
release of cytochrome c drives the assembly of the apoptosome and subsequent 
activation of caspase cascade that executes apoptosis (Neutzner et al. 2012). 
Therefore, mitochondria provide an amplification loop for initial pro-apoptotic 
signals, which spurs the completion of apoptosis.  
Moreover, mitochondrial calcium signaling contributes to the cytoplasmic 
response, mitochondrial metabolism and cell fate determination. Ca2+ enters 
mitochondria via the uniporter, allowing the Ca2+ accumulation down its 
electrochemical gradient and exits mitochondria via the Na+/Ca2+ antiporter by 
exchanging Ca2+ with Na+ (Santo-Domingo & Demaurex 2010). Mitochondrial Ca2+ 
uptake shapes the cytosolic Ca2+ signals upon the release of Ca2+ from ER in response 
to multiple stresses (Rizzuto et al. 2012). Besides buffering cellular Ca2+ ions, up-
regulated mitochondrial Ca2+ alters mitochondrial bioenergetics properties, 
production of ROS, as well as induction of autophagy and apoptosis. However, 
excessive Ca2+ accumulation in mitochondria favors the opening of the permeability 
transition pore (PTP), and initiates the release of caspase cofactors switching from 
physiological metabolic regulation to induction of apoptosis (Giorgi et al. 2012; 
Campanella et al. 2004).  
Section 2: Mitochondrial fusion and fission 
            Apart from a complex two-membrane structure, in cells mitochondria form 
intricate and highly dynamic tubular structures often referred as the mitochondrial 
network. The mitochondrial network constantly fuse and divide to maintain 
mitochondrial inheritance and health by managing their copy numbers and 
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morphologies in response to ever-changing physiological conditions (Chen & Chan 
2005; Westermann 2010). Mitochondrial fusion and fission dynamics cycle consists 
of four steps: biogenesis, fusion, fission and degradation (Archer 2013a). 
Mitochondrial biogenesis synthesizes new mitochondria to maintain mitochondrial 
copy numbers, through integration of proteins from both the nuclear and 
mitochondrial genomes (Jornayvaz & Shulman 2010). The dynamic behavior of 
mitochondrial fusion and fission forms an incorporated system to balance 
mitochondrial morphology and shape mitochondrial compartments. Increasing fusion 
activity leads to elongated mitochondrial tubules, whereas increasing fission activity 
antagonizes fusion and results in short and fragmented mitochondria. The combined 
mitochondrial fusion and fission dynamics and mitochondrial specific autophagy 
(mitophagy) are actively regulated in response to metabolic stress and mitochondrial 
damage as a quality control system (Chen & Chan 2009). Furthermore, mitochondrial 
fusion dilutes damaged materials, including mutated mtDNA and oxidized proteins, 
by improving the exchange of mitochondrial content. When mitochondrial damage 
exceeds a critical level, asymmetric mitochondrial fission divide and isolate aberrant 
mitochondria, allowing them to be packaged into autophagic vacuoles and then 
transported to lysosome for elimination by mitophagy (Archer 2013b; Twig et al. 
2008). 
Subsection 1: Control of mitochondrial fusion 
A) Mitofusins: The first known mitochondrial fusion protein, Fuzzy onion 1 protein 
(Fzo1p), was identified in Drosophila melamogaster in 1998 (Rapaport et al. 1998). 
Fzo1p is a transmembrane GTPase with two homologues Mitofusin1 (Mfn1) and 
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Mitofusin2 (Mfn2) in mammalian cells. Both Mfn1 and Mfn2 are integral OMM 
proteins with the bulk of the polypeptide facing the cytoplasm mediating OMM 
fusion. They share similar domain organization with a N-terminal GTPase domain to 
mediate membrane remodeling, two transmembrane domains and coil-coil domain 
responsible for protein interaction. Mfn1 and Mfn2 interact with each other via 
heptad repeat region (HR2) to mediate mitofusin oligomerization by assembling a 
dimeric antiparallel coiled-coil structure. Mitofusin homodimer or heterodimer tethers 
adjacent mitochondria to promote mitochondrial fusion activity in a hook and loop 
mechanism (Koshiba et al. 2004). Although Mfn1 and Mfn2 coordinate with each 
other to support fusion events, they exhibit different GTPase activity and are 
diversely expressed in various tissues, fulfilling distinct roles in cellular physiology 
(Sebastian et al. 2012; Schneeberger et al. 2013; Mourier et al. 2015; de Brito & 
Scorrano 2008). While Mfn1 and Mfn2 knockouts are embryonically lethal (Chen et 
al. 2003), conditional knockout mice ubiquitously lacking Mfn1 survived through 
adulthood with no obvious defects, whereas mice lacking Mfn2 presented a 
degeneration of purkinje cells and exhibit severe movement defects and die in the 
early postnatal period (Chen et al. 2007).  
            Mitochondria convert from filamentous network into short round structures 
upon the addition of apoptotic stimuli, suggesting that mitochondrial steps in 
apoptosis are molecularly linked to inhibition of mitochondrial fusion. Mfn1 is 
phosphorylated by Mitogen-activated protein (MAP) kinase cascade member 
extracellular-signal-regulated kinase (ERK) at atypical targeting site in HR1 domain, 
which is essential for modulating mitochondrial fusion via affecting its oligomeric 
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status, as well as apoptosis by influencing oligomerization of the OMM-associated 
pro-apoptotic protein Bak (Pyakurel et al. 2015). On the other hand, in healthy cells, 
Mfn2 promotes mitochondrial fusion by regulating pro-apoptotic Bcl2 family 
member Bak and Bax. In addition, Mfn2 induces apoptosis in hepatocellular 
carcinoma cells by triggering mitochondrial Ca+ influx from the ER, which opens the 
mitochondrial membrane permeability transition pore (MPTP) and releases 
cytochrome c and AIF (Wang et al. 2015). In addition, Bax and Bak induce 
mitochondrial fusion by altering Mfn2 oligomerization, subcellular distribution and 
membrane mobility in healthy cells, suggesting that Bax and Bak are also required for 



















Figure 1.1 The mechanism of Mitochondrial Fusion. 
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B) Opa1: Inner mitochondrial membrane fusion is mediated by Optical Atrophy 1 
(Opa1), which also belongs to the dynamin family of large GTPases. Opa1 has 
multiple isoforms, resulting from differential splicing of mRNA and proteolytic 
processing in the mitochondrial matrix and the intermembrane space. For example, 
Opa1 is encoded as a precursor that can be cleaved by mitochondrial processing 
peptidase (MPP) to produce the long isoform, and inner membrane peptidase zinc 
metallopeptidase OMA1 at S1 cleavage site (Ehses et al. 2009; Head et al. 2009) or 
the i-AAA protease Yme1L at C-terminal S2 cleavage site to produce the short 
isoform (Song et al. 2007). The long isoform, integrated in the IMM, and short 
isoform, residing in the intermembrane space, functionally complement each other for 
mitochondrial fusion (Anand et al. 2014). Opa1 processing mediated by 
mitochondrial proteases is important for regulation of mitochondrial morphology and 
metabolism. It has been reported that stimulation of Opa1 processing strongly 
correlated with induction of mitochondrial fragmentation (Ishihara et al. 2006). 
OMA1 is required in stress-induced cleavage of Opa1 and subsequent mitochondrial 
fragmentation, while loss of YME1L directly causes mitochondrial network 
fragmentation (Anand et al. 2014). In addition, Opa1 processing is also associated 
with mitochondrial integrity, including membrane potential, cristae remodeling and 
apoptosis. Disruption of mitochondrial membrane potential by mitochondrial 
uncoupler CCCP enhances accumulation of Opa1 short isoforms and is associated 
with mitochondrial fragmentation (Zhang et al. 2014). In addition, Opa1 protects cells 
from apoptosis independently of mitochondrial fusion (Frezza et al. 2006). OMA1 
mediated Opa1 processing is activated by Bak and Bax oligomerization, and 
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subsequently the long isoform of Opa1 is eliminated by intrinsic pro-apoptotic stimuli 
(Jiang et al. 2014). Activation of OMA1 and Opa1 processing lead to disassembly of 
Opa1 oligomers and remodeling of cristae junctions, which results in delayed release 
of cytochrome c mobilization from mitochondrial cristae and, thus, inhibition of 
apoptosis (Yamaguchi et al. 2008). 
Subsection 2: Control of mitochondrial fission 
A) Drp1: Mitochondrial fission is mediated by Dynamin-related protein 1 (Drp1) in 
mammalian cells and its homolog Dnm1p in yeast (Labrousse et al. 1999; Smirnova 
et al. 2001). Similar to mitochondrial fusion proteins, Drp1 belongs to the dynamin 
superfamily. It has been shown that Drp1 shares similar structural features with 
dynamin including a N-terminal GTPase domain which binds to GTP and stimulates 
hydrolysis, a middle domain, an insert B and a C-terminal assembly domain (also 
named GTPase effector domain, GED) (Van Der Bliek 1999). Drp1 resides in the 
cytosol as homodimer or tetramer and is recruited to the OMM at the prospective 
mitochondrial fission sites. Upon recruitment, Drp1 self-assembles as spiral-like 
oligomers through intramolecular and intermolecular interaction with the GED 
domain, GTPase domain and middle domain (Griffin et al. 2005; Cerveny et al. 
2007). Drp1 oligomerization enhances its GTP hydrolysis activity, which mediates 
membrane constriction and scission of mitochondrial tubules (Ingerman et al. 2005). 
Distinct posttranslational modifications and cellular signaling pathways regulate Drp1 
activation. Drp1 has several conserved phosphorylation sites, including serine 656, 
serine 637 and serine 616, which are critical for its activation and inactivation. Serine 
656 is phosphorylated by cyclic AMP-dependent protein kinase to inactivate Drp1 
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translocation, and is dephosphorylated by Calcinerurin (CN) to activate Drp1 
recruitment and promote mitochondrial fission (Cribbs & Strack 2007). CN also 
dephosphorylates Drp1 at serine 637 in response to mitochondrial depolarization and 
cytosolic calcium accumulation, promoting Drp1 translocation to the OMM 
(Cereghetti et al. 2008). Drp1 also mediates mitotic mitochondrial division, which 
ensures mitochondria to be equally and uniformly distributed to daughter cells. 
Phosphorylation of Drp1 by cyclin B-CDK1 at serine 616 activates Drp1 and 
inducing mitochondrial fission in mitosis (Taguchi et al. 2007). The activation of 
Drp1 is reflected by the elevated ratio of serine 616 to serine 637 phosphorylation 
(Rehman et al. 2012). Recent studies also implicate a close link between Bcl2 family 
proteins and Drp1 activity. Bax colocalizes with Drp1 at subsequent mitochondrial 
fission sites during apoptosis (Karbowski et al. 2002). The presence of Bax/Bak 
oligomerization upon apoptosis stimulation activates and stabilizes mitochondrial-
associated Drp1 via SUMOylation, which increases GTPase activity of Drp1 and 
stimulates mitochondrial fission in Bax/Bak-dependent apoptosis (Wasiak et al. 2007).  
B) Mitochondrial receptors of Drp1: The recruitment of Drp1 to the mitochondria 
is mediated by an array of OMM-associated receptor proteins, including Mff 
(Mitochondrial fission factor), Fis1 (Mitochondrial fission protein 1) and MiD49/51 
(Mitochondrial dynamics protein of 49 kDa and 51 kDa) complex. 
  The sequence of Mff features a short N-terminal repeat, a middle segment 
with strong coiled-coil forming propensity and a membrane anchor C-terminal 
hydrophobic segment. Depletion or downregulation of Mff produces interconnected 
mitochondria and partially inhibits CCCP-induced mitochondrial fragmentation 
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(Gandre-Babbe & van der Bliek 2008). Mff localizes in puncta on the OMM and is 
able to multimerize on OMM independent of Fis1 complex. It interacts with Drp1 
both in vivo and in vitro, and regulates mitochondrial recruitment of Drp1, through 
the N-terminal cytosolic region (Otera et al. 2010). In addition to mitochondrial 
division, Mff, together with Drp1, also contributes to peroxisomal fission. 
Peroxisome-specific division factor Pex11p interacts with Drp1 via Mff, and mediates 
peroxisome division under a similar scenario of mitochondrial fission (Itoyama et al. 
2013).  
            Fis1, another mitochondrial outer membrane protein, was proposed to 
function as a Drp1 receptor on the outer mitochondrial membrane. The domain 
organization of Fis1 features a N-terminal tetratricopeptide-repeat (TPR)-like domain 
exposed to the cytoplasm, and a C-terminal transmembrane domain to serve as a 
membrane anchor (James et al. 2003). In yeast, Fis1 is the sole factor mediating Drp1 
recruitment to mitochondria by binding to Dnm1p through adaptor proteins Mdv1 and 
Caf4 via TPR motif (Zhang & Chan 2007). The role of Fis1 in mitochondrial 
recruitment in mammalian cells is controversial. While exogenous Fis1 expression 
induced mitochondrial fragmentation (Yoon et al. 2003), it has been reported that 
ablation of Fis1 has no effect on mitochondrial morphology and subcellular 
localization of Drp1 (Otera et al. 2010). However, reduction of Fis1 expression 
inhibited mitochondrial translocation and conformational change of pro-apoptotic 
protein Bax, as well as promoted ROS generation and loss of mitochondrial 
membrane potential. Overexpression of Fis1 induced cell death and cytochrome c 
release, further pointing to a role of Fis1 in cell death (Lee et al. 2004). In addition, 
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ectopic expression of Fis1 promotes peroxisomal fission, while silencing of Fis1 
causes tubulation of peroxisomes, providing further evidence supporting the role for 
Fis1 in mammalian cells, in peroxisome morphogenesis, rather than mitochondrial 
fission (Shen et al. 2014). 
            MiD49 and MiD51 are two OMM proteins encoded by gene Smith-Magenis 
syndrome 7/7L (SMCR7/7L). MiD49/51 are N-terminally anchored in the 
mitochondrial outer membrane with C-terminal cytosolic domains. Unlike Fis1 and 
Mff, MiD49/51 do not localize on the peroxisomes (Palmer et al. 2013), which point 
to a more specific role in regulating mitochondrial dynamics. High expression of 
MiD49/51 results in elongated mitochondrial tubules, whereas low expression of 
MiD49/51 does not alter mitochondrial morphology (Palmer et al. 2011a). While 
Fis1-/-/Mff-/- cells display defects in Drp1 recruitment and are highly resistant to 
CCCP-induced mitochondrial fragmentation, overexpression of MiD49 or MiD51 in 
Fis1-/-/Mff-/- MEFs rescues recruitment of Drp1 to mitochondria and undergoes rapid 
shortening upon CCCP treatment, suggesting that MiD49/51 can mediate 
mitochondrial fission in the absence of Fis1 and Mff. Immunofluorescence analysis 
display that MiD49/51 form foci and constriction rings around mitochondria 
independent of Drp1, while co-immunoprecipitation shows that they directly interact 
with Drp1 (Losón et al. 2013). Collectively, the evidence suggests that they act as 
scaffolds for Drp1. The structure of MiD51 has been further studied. X-ray 
Crystallography demonstrates that MiD51 contains a nucleotidyltransferase domain 
that binds ADP and GDP with high affinity, however, mitochondrial fission still 
occurs at foci formed by a MiD51 nucleotide binding mutant, suggesting that the 
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nucleotidyltransferase is not directly relevant to the fission process (Losón et al. 
2014). In addition, MiD51 is able to recruit Drp1, promote its assembly with MiD51 
and GTP hydrolysis at constriction sites via a surface loop (residues 238-242), which 
is also well conserved in MiD49, implying for the role of MiD49/51 in promoting 
Drp1-dependent mitochondrial fission independently of ADP binding (Richter et al. 
2014). Apart from mitochondrial fission, another group proposed a role of MiD49/51 
(also called mitochondrial elongation factor 1/2; MIEF1/2) in mitochondrial fusion. 
In their hands ectopic expression of MiD49/51 resulted in extensive mitochondrial 
elongation and promotes mitochondrial fusion, whereas depletion of endogenous 











Subsection 3: Mitochondrial fusion and fission in disease 
            Imbalance of mitochondrial fusion and fission are implicated in various 
diseases and disorders including cancer, neurodegenerative, endocrine and 
cardiovascular diseases.  
A) Cancer: Generally, cancer cells exhibit excessive proliferation and resistance to 
apoptosis, which hallmarks the importance of mitosis in tumor formation. 
Mitochondrial fission in mitosis, called mitochondrial mitotic division, coordinates 
mitochondria distribution in mitotic cells, ensuring equitable distribution of 
mitochondria to daughter cells. At G1/S phase, inhibition of Drp1 leads to 
mitochondrial hyperfusion, which triggers DNA replication and cyclin E 
accumulation (Qian et al. 2012). Mitochondrial mitotic division is substantially 
coordinated by cyclin B1-CDK, a regulatory protein that contributes to cell cycle 
progression and Drp1 activation (Taguchi et al. 2007). Increased mitochondrial 
fission, resulting from an unbalanced Drp1 phosphorylation ratio of serine 616 to 
serine 637, has been shown in lung cancer cells. Drp1 inhibition by Drp1 inhibitor 
mdivi1, Drp1 siRNA or adenoviral Mfn2 have been used as therapies that inhibit cell 
proliferation and induces apoptosis, resulting in regression of tumor in a 
xenotrasplantation model (Rehman et al. 2012). 
B) Alzheimer’s Disease: Alzheimer’s Disease (AD) is a chronic neurodegenerative 
disorder, characterized by memory loss, language problems, mood swings and 
behavior issues. The pathology of AD is distinguished by formation of amyloid 
plaques, neurofibrillary tangles and loss of connections between neurons. Abnormal 
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nitric oxide production in AD neurons has been shown to trigger Drp1 dimerization 
and mitochondrial fission via S-nitrosylation of Drp1 at cysteine 644. Consistent with 
this, levels of S-nitrosylated Drp1 are elevated in brains of AD patients (Cho et al. 
2009).  However, this molecular link between S-nitrosylation of Drp1 and AD 
remains controversial. Another report showed no significant difference of S-
nitrosylated Drp levels in brains of age-matched normal and AD patients. Rather than 
S-nitrosylation, NO was found to trigger Drp1 phosphorylation at serine 616 resulting 
in activation of Drp1-dependent mitochondrial fission (Bossy et al. 2010). 
 C) Huntington’s Disease: Huntington’s Disease (HD) is an autosomal dominant 
disease characterized by symptoms such as choreoathetosis, dementia and premature 
death. The most common genetic cause of HD is the mutation of a protein called 
huntingtin (Htt) encoded by HTT gene with expansion of a CAG (cytosine-adenine-
guanine) nucleotide triplet repeats, producing a chain of glutamine known as a 
polyglutamine tract (polyQ tract). A sequence of 36 or more CAG yields a misfolded 
form of Htt, called mHtt (mutant Htt), which forms protein aggregates that are 
believed to interfere with neuronal function in the brain (Beal & Ferrante 2004). It 
has been shown that mHtt triggers mitochondrial fragmentation in HD patient’s 
fibroblasts and in a mouse model of HD prior to neurological deficits, via interacting 
with Drp1 and stimulating its GTPase activity (Song et al. 2011). Notably, increased 
levels of Drp1 S-nitrosylation were found in transgenic mouse model of HD and HD 
patients, and was proposed to induce early mitochondrial fragmentation followed by 
dendritic spines loss (Haun et al. 2013). 
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 D) Charcot-Marie-Tooth Disease:  Charcot-Marie-Tooth Disease is a group of 
genetically inherited disorders of the peripheral nervous system, which is 
characterized by progressive loss of muscle tissue and touch sensation. The subtype 
Charcot-Marie-Tooth disease type 2A (CMT2A) is due to autosomal dominant 
mutations of Mfn2 in neurons. More than 80 Mfn2 mutations have been reported in 
CMTA2 patients. The molecular pathogenic mechanisms is possibly due to mutated 
Mfn2 forming mitochondria clusters and clots, which impairs mitochondrial transport 
along axons towards the synapses damaging mitochondrial function in neurons (Klein 
et al. 2011; Züchner et al. 2004).  
 E) Autosomal dominant optic atrophy: Opa1 has been clinically reported as the 
most frequently mutated gene in autosomal dominant optic atrophy (ADOA), an optic 
neuropathy due to the loss of optic nerve fibers. ADOA is a mitochondriopathy that 
primarily affects retinal ganglion cells and their axons that transfer the visual signal 
from photoreceptors to the lateral geniculus in the brain. Dysfunctional Opa1 
mutations found in patient fibroblasts revealed alterations of mitochondrial 
respiration activity, reduced energetic coupling and higher sensitivity to apoptosis 
(Kao et al. 2015). However, the mechanism of how Opa1 causes ADOA is still 
controversial. 
Section 3: The role of F-actin in mitochondrial fission 
Subsection 1: The role of F-actin in dynamin-mediated membrane remodeling 
            Dynamin superfamily proteins, including canonical Dynamins 1 and 2, Drp1, 
Mfns and Opa1, localize at membrane remodeling sites during many cellular 
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processes such as endocytosis, organelle morphogenesis, cell motility and 
phagocytosis. Dynamin1 featuring GTPase domain, pleckstrin homology (PH) that 
binds phosphatidylinositol lipids for membrane association, Proline-rich tail domain 
(PRD) that binds to Src homology 3 (SH3) domain of actin-binding proteins forms 
helical polymers as mechanochemical enzymes (Faelber et al. 2012). As a bridge, 
dynamin links actin cytoskeleton to membrane remodeling via various direct and 
indirect actin-binding proteins. Dynamin can bundle with actin filaments directly 
through the stalk region. Point mutation in the actin-binding domain of dynamin 
results in aberrant membrane ruffling and defective actin filaments assembly, whereas 
short actin filaments promote dynamin assembly into higher order structures, 
releasing actin-capping protein gelsolin (Gu et al. 2010a). The indirect connection of 
dynamin and actin filaments via actin regulatory proteins may also help position 
dynamin and generate membrane tension at endocytic sites (Ferguson & De Camilli 
2012). Double knockout of Dynamin1 and Dynamin2 results in massive tubulation 
coated with actin meshwork nucleated by Arp2/3 complex and BAR binding protein 
endophilin 2, a group of proteins assisting dynamin-mediated membrane scission, at 
clarthin-dependent endocytic sites. The accumulation of endophilin 2 around the neck 
of arrested endocytic clathrin-coated pits depends on the activity of Arp2/3 complex 
(Ferguson et al. 2009). However, in the case of Shiga toxin-induced clathrin-
independent endocytosis, actin was localized on membrane invaginations in 
endophilin A2-depleted cells, whereas endophilin 2 localized on the Shiga toxin-
induced tubules in the absence of dynamin (Römer et al. 2010). Thus, actin, dynamin 
and endophilin 2 independently contribute to clathrin-independent tubulation. 
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Furthermore, another report indicates that membrane tension determines the actin 
dependence of clathrin-coated assembly (Boulant et al. 2011). Elevated membrane 
tension stalls clarthin assembly and sequesters local actin polymerization to endocytic 
sites. Actin meshwork is the driving force for membrane invagination and 
constriction in the latter stage when clathrin polymerization and assembly is hindered 
(Boulant et al. 2011). Even with the recent progress supporting the importance of 
actin cytoskeleton in clathrin-mediated endocytic processes, the mechanism of how 
dynamin interacts and connects actin cytoskeleton to membrane remodeling still 
remains unclear.  
Subsection 2: The role of F-actin in mitochondrial fission 
Recent studies reveal that actin cytoskeleton also take part in membrane 
constriction during mitochondrial fission, however the mechanism and degree to 
which F-actin contributes to mitochondrial fission remains ill-defined and 
controversial. Sheetz and colleagues first addressed the effects of F-actin 
polymerization on mitochondrial morphology (Kurt J De Vos et al. 2005). Disruption 
of F-actin by cytohalasin D and Latrunculin A/B did not affect mitochondrial tubules 
phenotype in CV1-4A and HeLa cells, indicating that F-actin was not required for 
maintenance of mitochondrial shape. Later however, other reports suggested that 
interfering with actin cytoskeleton altered mitochondrial morphology. Latrunculin 
application decreased mitochondrial size and shortened mitochondrial length in 
neurite and growth cone (Beck et al. 2012). Furthermore, overexpression of actin 
point mutants distinctively regulates mitochondrial morphology. While ectopic 
expression of actin R62D, which favors G-actin, decreased mitochondrial size and 
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occupancy, polymerization-competent actin G15S expression favoring F-actin 
assembly increased mitochondrial tubule size. These data suggest that elevated G-
actin level results in mitochondrial fragmentation and decreased mitochondrial size 
and neurite mitochondrial occupancy in growth cones. In contrast to these findings, 
Higgs and colleagues reported that Latrunculin B treatment significantly increased 
mitochondrial length in U2OS cells (Korobova et al. 2013).  
            Nevertheless, pharmacological inhibition of actin polymerization altered 
Drp1-dependent and -independent mitochondrial fission and Drp1 recruitment in 
distinct ways. F-actin disruption by addition of Cytochalasin D or Latrunculin A 
reversed Drp1-dependent mitochondrial fission caused by ATP synthase inhibitor 
oligomycin or mitochondrial permeability transition pore inhibitor cyclosporine A 
(Kurt J De Vos et al. 2005). Moreover, immunofluorescence and Western blot 
analysis showed that inhibition of F-actin polymerization did not affect Drp1 patterns 
on mitochondria, however Drp1 recruitment initiated by mitochondrial fission was no 
longer increased (Kurt J De Vos et al. 2005), suggesting that F-actin polymerization 
is required during Drp1 recruitment from cytosol to mitochondria, but may not affect 
the existing mitochondrial Drp1 localization. A work by Cossart and colleagues 
revealed that cytochaslasin D reduced the number of cells displaying fragmented 
mitochondrial network induced by the pore-forming toxin listeriolysin O (LLO), 
indicating that action of actin filaments assembly is involved in LLO induced Drp1-
independent mitochondrial fragmentation (Stavru et al. 2013). LLO induced Drp1-
independent mitochondrial fission occurrs at ER-mitochondria contact sites, 
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supporting the possibility that in the absence of Drp1, actin filaments participate in 
mitochondrial fission via the ER-mitochondria contacts.  
            Inverted formin 2 (INF2), is a vertebrate protein that facilitates both actin 
assembly and disassembly. Higgs and colleagues reported that INF2 regulates 
mitochondrial fission in an actin-dependent step (Korobova et al. 2013). 
Downregulation of total INF2 and specific suppression of the prenylated (CAAX) 
isoform of INF2 that tightly bound to ER in U2OS cells resulted in mitochondrial 
elongation and decreased Drp1 puncta on the mitochondria. In contrast, constitutively 
active INF2-A149D causes a decrease in mitochondrial length and accumulation of 
Drp1 puncta on constricted mitochondria. Thus, these data suggest INF2 may 
facilitate Drp1 mediated mitochondrial fission by assisting Drp1 constriction around 
ER-mitochondria sites.  Furthermore, INF2-A149D displayed a higher number of 
actin-enriched ER-mitochondrial contacts, and induced mitochondrial fragmentation, 
which was antagonized by LatB treatment, suggesting that INF2 involvement in 
mitochondrial fragmentation is actin dependent. Thus, it has been proposed that INF2 
assists Drp1 mediated mitochondrial fission at ER-mitochondrial contact sites via 
activating actin polymerization, which may help position Drp1 at constriction sites 
and generate membrane force. 
            To further clarify the mechanism of how F-actin controls mitochondrial 
dynamics, the role of the actin motor protein myosins was also investigated. Myosins, 
a family of ATP-dependent motor proteins sharing properties of actin binding and 
force transduction, are responsible for actin-based motility. Myosins molecules 
feature a head domain that binds F-actin and generates force by ATP hydrolysis to 
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walk along the filaments, a neck domain acting as a connector and a tail domain 
carrying cargo molecules. Non-muscle Myosin II is a major type of motor protein 
providing contractile properties and is regulated by phosphorylation of heavy and 
light chains. Loss of function allelles of Drosophila homolog of myosin II heavy 
chain and light chain, zipper (zip) and spaghetti squash (sqh), in fly neurons lead to 
elongated neuronal mitochondria and less Drp1 association with mitochondria. In 
addition, F-actin immunoprecipitation by biotinylated phalloidin shows that the level 
of mitochondrial F-actin decreased when expressing loss of function alleles of zip or 
sqh (DuBoff et al. 2012). These data suggest that myosin II acts as a linker 
connecting F-actin and mitochondria, regulating mitochondrial fission in fly neurons. 
Furthermore, a recent study showed that myosin II also participate in the process of 
mitochondrial division in mammalian cells (Korobova et al. 2014a). In U2OS cells 
myosin II inhibitor Blebbistatin, but not Arp2/3 inhibitor CK666, significantly 
increased mitochondrial length and partially inhibited INF2 A149D induced 
mitochondrial fragmentation, suggesting that INF2 is acting in an Arp2/3 independent 
manner through myosin II. The subcellular localization of myosin II was further 
investigated to address the role of myosin II during F-actin dependent mitochondrial 
fission. Myosin II punctas, labeled by serine 19-phosphorylated myosin light chain 
(anti-P-MRLC) were found to be enriched at mitochondrial constriction sites. These 
punctas were significantly decreased when actin polymerization was inhibited by 
Latrunculin B and by INF2 downregulation. Live cell microcopy showed that low 
expression of GFP fused myosin IIA accumulated transiently at mitochondrial 
constriction sites. Thus, myosin II was proposed to mediate the membrane 
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constriction step during mitochondrial fission in an actin-dependent manner. 
Suppression of myosin II reduced the number of mitochondrial associated Drp1 
puncta, suggesting that myosin II may serve as a docking molecule for Drp1.              
Section 4: Ubiquitin-proteasome degradation in outer mitochondrial membrane 
associated pathway 
Subsection 1: Ubiquitin proteasome system: an overview 
Ubiquitin (Ub) is a ubiquitous 76 amino acid protein. Ub can be covalently 
linked to the lysines of target proteins, in the process known as ubiquitination. Ub 
binds to lysine residues on the protein substrate via an isopeptide bond or to the 
amino group of the N-terminus via a peptide bond.  Ubiquitination acts as a signal for 
proteasome or lysosome degradation, as well as cellular signal transduction to 
regulate protein activity and interactions. Ubiquitination can be categorized as either 
monoubiquitination or polyubiquitination. Monoubiquitination occurs through an 
isopeptide bond generated between ubiquitin’s glycine and substrate’s lysine. 
Polyubiquitination is the formation of an Ub chain on a single lysine of the substrate 
protein, which is characterized by linking the C-terminal glycine of an Ub molecule 
to the specific lysine residue of already conjugated Ub molecules (e.g. K48, K63, 
K11). Primarily K48 and K11 polyubiquitination regulate proteasomal degradation of 
substrate proteins, whereas other types of Ub chains may be related to regulation of 
protein activities in various cellular processes, such as endocytic trafficking, DNA 
transcription and repair, and immune response and inflammation (Herrmann et al. 
2007; Popovic et al. 2014). The ubiquitination cascade requires three steps: activation 
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by Ub-activating enzymes (E1s), conjugation by Ub-conjugating enzymes (E2s) and 
ligation by Ub ligase (E3s). Ub chains can be also removed from the substrate 
proteins by deubiquitinases (DUBs). Whereas the number of E1 and E2 are relatively 
limited, the diversity of E3 ligases allows the binding specificity of substrates during 
the process. The human genome encodes more than 600 putative E3 Ub ligases 
(Sévère et al. 2013). There are four major families of E3 Ub ligases: HECT (E6AP 
carboxyl terminus) domain, RING (Really Interesting New Gene) -finger, and RING 
related E3s such as U-box domain and PHD-finger. HECT domain accepts ubiquitin 
from E2 conjugating enzyme in the form of a thioester and directly transfers ubiquitin 
to targeted substrates. RING-finger domain is the largest family of E3 ligases 
containing a canonical Zn2+ coordinating domain that consists of conserved cysteine 
and histidine residues forming a cross-brace topology. RING finger domain 
simultaneously binds E2 enzymes and their substrates and serves as a scaffold to 
transfer ubiquitin to substrates (Metzger et al. 2012). U-box E3 ligases containing a 
70 amino acid motif is a modified RING finger domain with zinc-binding sites 
replaced by hydrogen-bonding networks (Hatakeyama et al. 2001).  
            The significance of the Ub/proteasome degradation system (UPS) in 
regulating mitochondrial physiology through mediating mitochondrial protein 
degradation has been supported by the recently published evidence. E3 Ub ligases, 
which are responsible for mitochondrial protein degradation, localize either on the 
OMM or transiently interact with the mitochondria. The majority of evidence points 
to a role of the UPS in the control of OMM-associated protein degradation in a 
process similar to the ERAD (ER-associated protein degradation) pathway.   
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Subsection 2: Role of E3 Ub ligases in control of mitochondrial steps in apoptosis 
Apoptosis is a type of programmed cell death process to remove dying cells 
from the organisms and is organized by cysteine-aspartic proteases called Caspases. 
Apoptotic signaled cytochrome c release is initiated from mitochondria to cytosol 
mediated by Bcl2 (B-cell lymphoma 2) family proteins and activates Caspases to 
execute programmed cell death. The balance between anti- and pro-apoptotic Bcl2 
family serves as Caspases checkpoint by governing the OMM permeabilization. BH3-
only proteins, which promote apoptosis, are generally present in different 
compartments of the cell and are localized to the OMM upon apoptosis stimuli, 
whereas multi-BH domain proteins including both anti- and pro-apoptotic proteins 
reside on the OMM (Neutzner et al. 2012). The recruitment of BH3-only proteins to 
the OMM shifts the ratio of pro- and anti-apoptotic proteins and triggers the 
permeabilization of OMM, thereby causing the release of a number of proteins, such 
as cytochrome c and AIF from intermembrane space (IMS) to cytosol, initiating the 
Caspase cascade (Suen et al. 2008). The UPS controls Bcl2 family proteins in distinct 
pathways, indicating a vital role of Ub-dependent protein degradation in regulating 
the mitochondrial steps of apoptosis. 
Mcl1, a multi-BH domain anti-apoptotic Bcl2 family member, is rapidly 
degraded via the ubiquitin-proteasome system during apoptosis and upon cellular 
stress. Unlike other Bcl2 family proteins, Mcl1 has a short half-life of about 40-60 
min. The unstable nature of Mcl1 is utilized by various stress stimuli as a rapid signal 
cascade for mitochondrial stress sensor. Mcl1 turnover is regulated by distinct E3 Ub 
ligases including ARF-BP1/Mule and SCFFBW7. HECT domain E3 Ub ligase ARF-
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BP1/Mule interacts with Mcl1 via its unique BH3 domain and mediates Mcl1 K48-
linked polyubiquitination, thereby tagging Mcl1 for proteasomal degradation upon 
DNA damage-induced apoptosis (Inoue et al. 2013; Zhong et al. 2005). SCFFBW7 
(Skp1-Culin1-F-box complex containing the F-box substrate recognition factor 
FBW7) interacts with and targets Mcl1 for ubiquitination depending on Mcl1 
phosphorylation level (Inuzuka et al. 2011). Mutations of Mcl1 phosphorylation sites 
of glycogen synthase kinase 3 (GSK3) lead to both inhibition of Ub-dependent 
degradation and loss of interaction between Mcl1 and SCFFBW7 complex (Maurer et 
al. 2006). Depletion of SCFFBW7 complex hinders Mcl1 degradation causing 
accumulation of Mcl1 in DNA damage induced apoptosis (Inuzuka et al. 2011). 
Usp9x (Ubiquitin specific protease 9x) was reported to remove K48-linked Ub chain 
from Mcl1, thereby stabilizing Mcl1 in both untransformed cells and in tumors 
(Schwickart et al. 2010). The direct interaction between Usp9x and Mcl1 is inhibited 
by a GSK3 inhibitor, indicating that Mcl1 phosphorylation by GSK3 is critical for 
Usp9x deubiquitination. Increased Usp9x expression promotes cell survival in 
tumors, whereas knockdown of Usp9x enhances Mcl1 degradation and sensitizes 
cells to various apoptosis stimuli.  In addition to above discussed factors, p97 
(valosin-containing protein), a highly conserved AAA-ATPase, provides the driving 
force to extract Mcl1 from OMM, mediating the retrotranslocation of Mcl1 from the 
mitochondria to cytosol (Xu et al. 2011). Loss of membrane attachment allows p97 to 




            In addition to Ub-dependent degradation of Mcl1, accumulating evidence 
reports that mitochondrial turnover of pro-apoptotic protein Bax (Bcl2 associated X 
protein) is also regulated by Ub-proteasome system. Normally, dormant Bax 
monomers are either cytosolic or loosely attached to the OMM as an inactive form. 
Upon apoptosis induction, Bax changes its conformation and accumulates on the 
OMM, and subsequently induces OMM permeabilization, resulting in release of 
cytochrome c and other pro-apoptotic protein to cytosol (Wolter et al. 1997; Hsu & 
Youle 1998). IBRDC2, an IBR (in-between RING)-type E3 ligase, specifically 
accelerate the removal of active Bax from the OMM (Benard et al. 2010). IBRDC2 
translocates to mitochondria upon apoptosis induction, in synchrony with Bax 
activation. While overexpression of IBRDC2 increases Bax ubiquitination, 
knockdown of IBRDC2 leads to accumulation of active Bax on mitochondria and 
spontaneous apoptosis. Ub-proteasome system also regulates Bax activity through 
degradation of apoptosis related non-Bcl2 family proteins. RING domain E3 ligase 
BARD1 (BRCA1-associated RING domain 1) translocation to the mitochondria 
associates with stimulation of Bax oligomerization at OMM in response to the loss of 
mitochondrial membrane potential and apoptosis. Baxβ, an alternatively spliced 
variant of Bax, is constitutively active and closely regulated by proteasomal 
degradation (Tembe & Henderson 2007).  
Subsection 3: Role of Ub-proteasome system in control of mitochondrial fusion and 
fission 
The OMM-localized components of the UPS also regulate mitochondrial 
fusion and fission.  
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A) Ubiquitin-dependent control of mitochondrial fusion and fission proteins: 
OMM integral fusion proteins Mfn1 and Mfn2 are stabilized by proteasome inhibitor 
MG132 in mammalian cells, pointing to a role of Ub-proteasome system in Mfns 
turnover. MARCH5, a mitochondrial anchored E3 ligase with four transmembrane 
segments (Karbowski et al. 2007), is well-studied. MARCH5-/- MEFs are sensitized 
to cell death upon electron transport chain complex III inhibitor Antimycin A 
treatment, possibly by regulating Mfn1 degradation (Park et al. 2014). MARCH5 
binds to Mfn1, which has a shorter half-life about 4-6 hours, and subsequently 
ubiquitinates it depending on acetylation status of Mfn1. Under mitochondrial stress 
induced by Antimycin A, Mfn1 level is elevated and mitochondrial tubules are 
extensively elongated. At the same time, MARCH5-Mfn1 interaction and MARCH5-
dependent Mfn1 ubiquitination and degradation are significantly enhanced, along 
with increased acetylated Mfn1, providing a novel E3-substrate coupling on OMM in 
regulating mitochondrial dynamics and cell viability. Furthermore, cells with reduced 
MARCH5 levels display cellular enlargement and flattening accompanied by 
increased senescence-associated β-galactosidase (SA-β-Gal) activity (Park et al. 
2010). Ectopic expression of Mfn1 mutant in MARCH5 shRNA cells abolished the 
increase in SA-β-Gal activity, indicating that loss of MARCH5 promotes cellular 
senescence by Mfn1 accumulation on mitochondria. In addition, Mfn1 is 
ubiquitinated by MARCH5 at G2/M phase and degraded in a proteasome-dependent 
manner, postulating a new Ub-proteasome dependent cell-cycle regulatory 
mechanism (Park & Cho 2012). Mfn2 appears to localize to both mitochondria and 
ER, and was proposed to tether mitochondria and ER in addition to its role in 
 27 
 
mitochondrial fusion (de Brito & Scorrano 2008). It has been reported that, MARCH5 
can bind to and ubiquitinate only the mitochondrial subset of Mfn2 (Sugiura et al. 
2013). The resulting K63-linked ubiquitination promoted oligomerization of Mfn2 
and the attachment of mitochondria to the ER in a proteasomal degradation-
independent manner. Drp1 has been also identified as a physiological ubiquitination 
substrate of MARCH5 (Karbowski et al. 2007; Park et al. 2010).  
            In addition to the above discussed E3 Ub ligases, the OMM-associated 
deubiqutinase Usp30 has been also proposed to control mitochondrial membrane 
dynamics. Downregulation of Usp30 resulted in mitochondrial elongation(Nakamura 
& Hirose 2008; Yue et al. 2014). Mfn1, Mfn2 and other mitochondrial outer 
membrane proteins have been identified as the potential substrates of Usp30 in 
regulating mitochondrial dynamics (this will be discussed in chapter 4) (Yue et al. 
2014). 
B) SUMO-dependent control of mitochondrial fission: In addition to Ub, a 12 kDa 
small ubiquitin-like modifier (SUMO) also contributes to regulating mitochondrial 
dynamics. SUMOylation is a post-translational modification involving E1 heterdimer, 
E2 Ubc9 and E3-mediated multi-step cascade, by a mechanism similar to 
ubiquitination (Flotho & Melchior 2013). There are three SUMO (SUMO 1-3) 
paralogs in mammals. SUMO2 and SUMO3 differ by only a few N-terminal amino 
acids, whereas SUMO1 shares about 50% amino acid sequence with the other two. 
Unlike ubiquitination-targeted protein degradation, SUMOylation results in 
regulation of protein localization and activity, assembly or disassembly of protein 
complexes and modification of other posttranslational modification. Drp1 activity can 
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be modified by SUMOylation to regulate mitochondrial dynamics and response to 
various stresses. Pull-down results showed that Drp1 can be conjugated with SUMO1, 
and thereby protected from degradation (Harder et al. 2004). MAPL, an OMM 
anchored RING-finger E3 ligase, was reported to mediate Drp1 SUMOylation and 
reduce mitochondrial fusion rates promoting mitochondrial fission (Braschi et al. 
2009), supporting the notion that MAPL modulates mitochondrial dynamics through 
regulating Drp1 SUMOylation.  
            deSUMOylation of conjugated proteins occurs through highly active SUMO 
cysteinyl proteases, which recognize tertiary structure of SUMO and cleave it from 
conjugated substrates. In mammalian cells, silencing of cytosolic SUMO protease 
SENP5 resulted in increasing Drp1 SUMO-1-ylation, as well as enhanced 
mitochondrial Drp1 translocation and mitochondrial fragmentation (Zunino et al. 
2007). Another SUMO protease SENP3 is greatly reduced in response to 
oxygen/glucose deprivation, an in vitro model for ischaemia, increasing Drp1 SUMO-
2/3-ylation resulting in decreased Drp1 association with mitochondria (Guo et al. 
2013). Thus, loss of SENP3 decreased mitochondrial fragmentation and inhibited 
release of cytochrome c, establishing a crosstalk between unfolded protein response 
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Section 1: Introduction 
As discussed in the previous section, mitochondrial fusion and fission balance 
is critical for cellular homeostasis maintenance and mitochondrial function in 
response to stress. A wide spectrum of diseases such as peripheral nervous system 
disorder Charcot-Marie-Tooth neuropathy type 2A and autosomal dominant optic 
atrophy (ADOA) concerning deficiencies in the oxidative phosphorylation system 
(OXPHOS) includes genetic and biochemical alterations of mitochondrial fusion and 
fission (Archer 2013b; Westermann 2010; Chaturvedi & Beal 2013).  
Mitochondrial division is a multistep process relying on the action of several 
proteins. As discussed in detail in the previous section, mitochondrial recruitment of 
Drp1, the essential protein of mitochondrial fission, from the cytosol to the OMM is 
mediated by integral OMM-associated Drp1 receptors, Mff, MiD49/51, and Fis1 
(Palmer et al. 2013; Otera et al. 2010; Onoue et al. 2012; Losón et al. 2013). Upon 
recruitment to mitochondria, Drp1 forms homo- and hetero- oligomers, composing of 
spirals around constricted sites on mitochondria in the final steps of mitochondrial 
fission that mediate membrane scission (Sesaki et al. 2014). This process appears to 
be facilitated by ER tubules that colocalize with mitochondrial fission sites. 
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Subsequently, disassembly and retrotranslocation of Drp1 from mitochondria to 
cytosol completes the mitochondrial fission pathway. Recent evidence supports a role 
for the F-actin cytoskeleton in the mitochondrial fission process (Kurt J. De Vos et al. 
2005; Beck et al. 2012; Stavru et al. 2013; DuBoff et al. 2012; Palmer et al. 2011a; 
Korobova et al. 2014b; Korobova et al. 2013). Although many lines of evidence 
suggest the role of actin cytoskeleton in regulating mitochondrial morphology 
(overview in Chapter 1 Section 3), the exact mechanism remains unclear. Here in this 
chapter, I will discuss data supporting the notion that transient Drp1-independent de 
novo polymerization of F-actin on the OMM contributes to mitochondrial division in 
mammalian cells. 
Section 2: Materials and Methods 
Subsection 1: Cell culture 
HeLa cells, wild type mouse embryonic fibroblasts (MEFs), Drp1-/- MEFs 
were provided by Dr. H. Sesaki from Johns Hopkins University. Mff-/- MEFs and 
Mfn2-/- MEFs were provided by Dr. D. Chan from California Institute of Technology. 
HeLa cells and MEFs were cultured in Dulbecco’s Modified Eagle Medium (DMEM) 
supplemented with 10% heat-inactivated fetal bovine serum, 2 mM Glutamax, 1 mM 
sodium pyruvate, 1 mM nonessential amino acids, 100 U/ml penicillin in 5% CO2 at 
37°C. Drp1-/- MEFs were isolated from Drp1-/- E10.5 embryos and immortalized 
spontaneously by serial passage (over 30 times) (Wakabayashi et al. 2009).  Mouse 
embryonic stem cell lines containing gene trap Mff disruption (line AZ0438) was 
injected into blastocysts to generate mouse cell lines, which Mff-/- MEFs were 
 31 
 
isolated from (Losón et al. 2013).  Mfn2-/- MEFs were derived from Mfn2-/- e10.5 
embryos which were mechanically dispersed by repeated passage (Chen et al. 2003).  
 
Subsection 2: Transfection 
Cells were transfected with X-tremeGENE HP (Roche) or Lipofectamine 
2000 (Invitrogen) transfection reagents, according to manufacturer’s instructions. 
Cells were plated in 2-well chamber slides (model 1 German borosilicate; Labtec) or 
cell culture dish 18-24 hours before transfection (70%-90% confluency) and then 
incubated overnight. DNA were diluted with OPTI-MEM to a final concentration of 
0.01 ug/ul and mixed gently. Transfection reagent was directly added in to DNA 
diluent in a ratio of 1:3 (DNA (ug): Transfection reagent (ul)) without contact with 
the walls of the plastic tubes and mixed gently. Transfection reagent-DNA complex 
were incubated in room temperature for 30 min and then added to cells in a dropwise 
manner. Cells were incubated for 16-20 hours before analysis.  
Subsection 3: Cell cycle analysis 
Cell cycle arrest at G1/S phase is performed by double thymidine block. HeLa 
cells were treated with 2 mM thymidine for 18 hours to block DNA synthesis, 
followed by 3 washes with PBS and then releasing the cells into thymidine-free 
DMEM for 9 hours. After incubation in thymidine-free DMEM, cells were incubated 
with 2 mM thymidine for an additional 18 hours, followed by washing with PBS for 3 
times. Afterwards, cells were reincubated in thymidine-free DMEM to restart the cell 
cycle and fixed by 4% formaldehyde 8-10 hours after releasing from the thymidine 
block. Cell cycle status of the synchronized cells was examined by flow cytometry 
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using propidum iodide (PI) staining. Cells were harvested, gently vortexed to avoid 
clumping and fixed with 70% ethanol overnight at 4°C. After fixation, cells were 
washed with cold PBS and incubated with 500ul RNase and 500ul PI for 45 min in 
the dark, and then transferred to FACS (Fluorescence-associated cell sorting) tubes 
for flow cytometry to verify synchronization of cell cycle status. 
Subsection 4: DNA expression constructs 
mRuby-Lifeact construct (Riedl et al. 2008) was provided by Dr. T. Blanpied 
(University of Maryland School of Medicine, Baltimore, MD). mCherry-UtrCH was 
(Burkel et al. 2007) purchased from Addgene (plasmid 26740; deposited by W. 
Bement). The mito-YFP construct was descibed earlier (Karbowski et al. 2007). 
Drp1K38A was provided by Dr. C. Blackstone (NIH, Bethesda, MD) and was 
described earlier (Karbowski et al. 2002). 
Subsection 5: Immunofluorescence 
Immunofluorescence was performed as previously described (Benard et al. 
2010; Xu et al. 2011). For immunofluorescence, cells grown in 2-well chamber slides 
(model 1 German borosilicate; Labtec) were fixed with prewarmed 4% formaldehyde 
solution in PBS for 20 min at room temperature, and then permeabilized with 0.15% 
Triton X-100 solution in PBS for 20 min at room temperature. After blocking with 
7.5% BSA blocking buffer (Bovine Serum Albumin fraction V in PBS) for 45 min, 
samples were incubated with primary antibodies diluted in 7.5% BSA blocking buffer 
for 90 min at room temperature, followed by 3 washes with 7.5% BSA blocking 
buffer and incubation with secondary antibodies diluted in 7.5% BSA blocking buffer 
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for 60 min at room temperature. Samples were washed with PBS at room 
temperature, and imaged directly in PBS within 2 d after immunofluorescence 
processing. The primary antibodies were: anti-Tom20 polyclonal antibody (dilution 
1:2,000; clone FL-145; Santa Cruz Biotechnology, Inc.), anti-cytochrome c mAb 
(1:300; clone 6H2.B4; BD), and anti-Mff polyclonal antibody (1:1,000; ProteinTech). 
Secondary antibodies were anti–mouse or anti–rabbit Alexa Fluor 488 (1:500; 
Molecular Probes), or anti–mouse or anti–rabbit Alexa Fluor 546 (1:500; Molecular 
Probes). F-actin in fixed cells was detected using Alexa 546-Phalloidin, according to 
the manufacturer’s protocol (Molecular Probes). In brief, after blocking with 7.5% 
BSA in PBS, cells were incubated with 6.7 U/ml Alexa 546-Phalloidin in blocking 
buffer for 60 min at room temperature, washed and then processed for 
immunofluorescence with respective primary antibodies. 
Subsection 6: Image acquisition and analysis 
            Images were acquired using a fluorescent microscope (AxioObserver Z1; 
Zeiss MicroImaging), equipped with a 100/1.45 a-Plan-FLUAR objective lens (Zeiss 
MicroImaging), an ApoTome unit (enabling high-resolution structured illumination 
image acquisition), a Definitive Focus module, and a CCD camera (QuantEM 512SC; 
Photometrics) at room temperature. The ApoTome filters were set to maximum noise 
elimination. The software used for image acquisition was AxioVision 4.8 (Zeiss 
MicroImaging). Image cropping and global adjustments to brightness and contrast 
were performed using Photoshop CS6 software (Adobe). Live cell imaging was 
performed using the above-described system. Cells were grown in 2-well chamber 
slides (model 1 German borosilicate; Labtec) and imaged in Phenol Red–free 
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DMEM, supplemented with 10% heat-inactivated fetal bovine serum, 2 mM 
Glutamax, 1 mM sodium pyruvate, 1 mM nonessential amino acids, 100 U/ml 
penicillin, 100 mg/ml streptomycin, and 25 mM Hepes, pH 7.4, at room temperature.  
Section 3: Results 
Subsection 1: Abnormal accumulation of F-actin on the elongated mitochondria 
F-actin has been implicated to participate in Drp1-dependent and Drp1-
independent mitochondrial fission, as well as Drp1 recruitment from cytosol to 
mitochondria.  However, the molecular mechanism and the degree to which crosstalk 
between Drp1 activity and F-actin contribute to mitochondrial division remain 
unclear. First, I analyzed the spatial relation between F-actin and mitochondria in 
wild type and Drp1-/- MEFs. Cells were fixed and stained with Alexa-Phalloidin for 
F-actin and cytochrome c to detect mitochondria, followed by structured illumination 
imaging. I found that there were no overlap between Alexa-Phalloidin and 
cytochrome c in wild type MEFs, indicating that F-actin was not colocalizing with the 
mitochondria (Fig2.1A). In contrast, about 20% of Drp1-/- MEFs with elongated 
mitochondrial phenotype revealed a mitochondria-colocalizing pattern of F-actin 
(Fig2.1B). This colocalization was primarily restricted to the perinuclear 
mitochondria. In addition, we inhibited mitochondrial fission by transfecting 
Drp1K38A in HeLa cells. Drp1K38A is a dominant negative protein defective in its 
GTPase activity, leading to mitochondrial elongation and swelling. Only 5.7 ±	 4.6% 
HeLa cells displayed some F-actin colocalization with mitochondria (Fig.2.2A), while 
HeLa cells transfected with Drp1K38A exhibited F-actin colocalized with elongated 
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tubular, but not swollen mitochondria (Fig.2.2B), suggesting that in the absence of 
functional Drp1 F-actin accumulated on abnormally elongated mitochondrial 
networks. The spatial relation between F-actin and mitochondria was also tested in 
mitochondrial Drp1 receptor Mff knockout (Mff-/-) MEFs. Depletion of Mff resulted 
Figure 2.1 Mitochondrial F-actin localization in wild type and Drp1-/- MEFs. 
Wild type (A) and Drp1-/- (B) MEFs were fixed with 4% formaldehyde and then 
immunostained with Alexa-Phalloidin to detect F-actin (red on the overlay image) 
and anti-cytochrome c mAb for mitochondria (green on the overlay image), 
followed by structured illumination imaging. Higher magnifications of areas 




in mitochondrial elongation because Drp1 cannot be recruited to the OMM in Mff-/- 
MEFs. F-actin was also found to colocalize with mitochondria in about 34% of Mff-/- 
MEFs (Fig. 2.3), indicating that inhibition of mitochondrial fission either by loss of 
Drp1 or reduction of Drp1 interaction with mitochondria resulted in abnormal 
mitochondrial accumulation of F-actin. Confirming the specificity of F-actin 
Figure 2.2 Mitochondrial F-actin localization in Drp1K38A-expressing cells. 
Control HeLa cells (A) and HeLa cells transfected with Drp1K38A (B) were fixed 
with 4% formaldehyde and then immunostained with Alexa-Phalloidin to detect F-
actin (red on the overlay image) and anti-cytochrome c mAb for mitochondria 
(green on the overlay image), followed by structured illumination imaging. Higher 
magnifications of areas marked with white rectangles are shown in detail images. 
Bar: 20 µm; (detail) 5 µm. 
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colocalization with mitochondria in Drp1-/- and Mff-/- MEFs, no colocalization 
between F-actin and mitochondria was found in Mfn2-/- MEFs. Thus, these data 
suggests that accumulation of F-actin on elongated mitochondrial tubules was 
specifically induced under the scenario that mitochondrial fission is inhibited by 
depletion of Drp1 or Mff.  
 
Subsection 2: Transient de novo F-actin polymerization on the mitochondrial upon 
stress-induced mitochondrial fission   
            Transient F-actin assembly has been implicated in various membrane 
remodeling events such as dynamin-dependent endocytosis (Mooren et al. 2012). 
Furthermore, knockout of dynamin, a large GTPase essential for endocytotic vesicle 
Figure 2.3 Mitochondrial F-actin localization in Mff-/- MEFs. Mff-/- MEFs were 
fixed with 4% formaldehyde and then immunostained with Alexa-Phalloidin to 
detect F-actin (red on the overlay image) and anti-cytochrome c mAb for 
mitochondria (green on the overlay image), followed by structured illumination 
imaging. Higher magnifications of areas marked with white rectangles are shown 
in detail images. Bar: 20 µm; (detail) 5 µm. 
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scission, led to abnormal accumulation of F-actin at the defective vesicle scission 
sites (Ferguson et al. 2009). A similar scenario may also underlie mitochondrial 
accumulation of F-actin in mitochondrial fission deficient Drp1-/- and Mff-/- MEFs 
and HeLa cells transfected with Drp1K38A. 
            To verify this possibility, we tested the degree to which F-actin assembles on 
mitochondria upon stress-induced mitochondrial fission. Drp1 mediated 
mitochondrial fission can be induced by mitochondrial toxins, including the 
uncoupling agents carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP), 
and 2-[2-(3-Chlorophenyl) hydrazinylyidene] propanedinitrile (CCCP; Gandre-Babbe 
and van der Bliek, 2008; Palmer et al., 2011). Wild type MEFs and Drp1-/- MEFs 
were treated with 10 µM FCCP, followed by immunostaining with Alexa-Phallodin 
to detect F-actin and anti-cytochrome c antibody to detect mitochondria. At 2 min 
into FCCP treatment, about 100% of Drp1-/- MEFs displayed a clear mitochondrial 
accumulation of F-actin, in contrast to about 33% in the case of wild type MEFs (Fig. 
2.4). Similar mitochondrial F-actin accumulation was also detected in HeLa cells 
transfected with dominant negative mutant Drp1K38A (Fig. 2.5). Another 
mitochondrial toxin cytochrome c reductase inhibitor Antimycin A (AntA), was 
utilized to induce Drp1 dependent mitochondrial fission. As with FCCP treatment, 
mitochondrial accumulation of F-actin was more pronounced in Drp1-/- MEFs after 5 
min of 10 µM AntA treatment (Fig.2.6). In addition, mitochondrial accumulation of 
F-actin was also detected in about 100% of Mff-/- MEFs at 2 min of FCCP treatment 
(Fig.2.7A). I also tested mitochondrial colocalization of Drp1 in untreated and FCCP-
treated wild type MEFs and Mff-/- MEFs. Mff ablation significantly reduced 
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mitochondrial localization of Drp1. Furthermore there was only a minor increase in 
mitochondrial Drp1 in FCCP-treated cells (Fig.2.7B). Thus, mitochondrial 
accumulation of F-actin appears to preferentially occur in cells in which Drp1 fission 
complex formation is inhibited, and in control cells may occur before Drp1 activation. 
The mitochondria-enriched z-sections corresponding to the vertical middle 
part of the cells are shown in Fig.2.8. These images largely lack the cortical F-actin 
signal, which is detectable in the bottom of the cells, corresponding to z-sections 
below those enriched in the mitochondria. The typical z-stacks shown in Fig.2.8 







Figure 2.4 Mitochondrial F-actin localization in wild type and Drp1-/- MEFs 
upon 2 min FCCP treatment. Wild type (A) and Drp1-/- (B) MEFs were treated 
with 10 uM FCCP for 2 min, fixed with 4% formaldehyde and then 
immunostained with Alexa-Phalloidin to detect F-actin (red on overlay image) and 
anti-cytochrome c mAb for mitochondria (green on overlay image), followed by 
structured illumination imaging. Higher magnifications of areas marked with white 









Figure 2.5 Mitochondrial F-actin localization in Drp1K38A-expressing cells 
upon 2 min FCCP treatment. Control HeLa cells (A) and HeLa cells transfected 
with Drp1K38A (B) were treated with 10 uM FCCP for 2 min, fixed with 4% 
formaldehyde and then immunostained with Alexa-Phalloidin to detect F-actin 
(red on overlay image) and anti-cytochrome c mAb for mitochondria (green on 
overlay image), followed by structured illumination imaging. Higher 
magnifications of areas marked with white rectangles are shown in detail images. 











Figure 2.6 Mitochondrial F-actin localization in AntA-treated wild type and 
Drp1-/- MEFs. Wild type MEFs (A) and Drp1-/- MEFs (B) were treated with 
Antimycin A for 5 min and immunostained with anti-cytochrome c mAb (green on 
overlay image) and Alexa-Phalloidin (red on overlay image), followed by 
structured illumination imaging. Higher magnifications of areas marked with white 






Figure 2.7 Mitochondrial F-actin localization and mitochondrial association 
of Drp1 in FCCP treated Mff-/- MEFs. (A) Mff-/- MEFs were treated with FCCP 
for 2 min, fixed with 4% formaldehyde, and then immunostained with Alexa-
Phallodin to detect F-actin (red on overlay image) and anti-cytochrome c mAb to 
detect mitochondria (green on overlay image), followed by structured illumination 
imaging. Higher magnifications of areas marked with white rectangles are shown 
in detail images. Bar: 20 µm; (detail) 5 µm. (B) Colocalization of Drp1 with 
mitochondria was analyzed in wild type and Mff-/- MEFs. The values represent 
Mander’s correlation coefficient (Rr) that reveal the degree of association of pixels 
in different channels of the image. Rr = 1 indicates complete colocalization, 
whereas Rr = 0 indicates random colocalization, and Mander’s score roughly 
correlates with percentage of overlap. Data represent the mean ± SD of 15 
images/condition. Each image used for the analysis contained at least two cells. 
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Figure 2.8 Spatial relations of F-actin and mitochondria in FCCP-treated 
Drp1-/- MEFs. Drp1-/- MEFs treated with FCCP for 2 min were immunostained 
with anti-cytochrome c mAb (green on overlay images) and Alexa-Phalloidin (red 
on overlay images), followed by structured illumination imaging. The sequence of 
single z-sections (0.25 um intervals), from the bottom (A) to the top (N) of the 
cells is shown. Bar: 20 µm. 
 45 
 
            To further clarify the temporal mechanism of how F-actin is recruited to 
mitochondria, various cell types including HeLa cells, wild type MEFs, Drp1-/- MEFs, 
Mff-/- MEFs and Mfn2-/- MEFs, were treated with FCCP for various time periods 
ranging from 2 to 30 min (Fig. 2.9). The data showed an increase in the number of 
cells with F-actin positive mitochondria in FCCP-treated wild type, Drp1-/- MEFs, 
Mff-/- MEFs and Mfn2-/- MEFs upon treatment, peaking at 2-5 min of treatment, 
followed by a gradual decline in the number of cells with F-actin positive 
mitochondria. Furthermore, parallel analysis of Mfn-/- MEFs and HeLa cells revealed 
transient increases in the number of cells with F-actin-positive mitochondria 
occurring at comparable rates as FCCP-treated wild type MEFs. Similar to FCCP 
treatment, AntA treatment also induces a transient increase of mitochondrial F-actin 
in both wild type and Drp1-/- MEFs. In sum, these data suggests that F-actin 
transiently accumulates on the mitochondria during stress-induced mitochondrial 
fission. The temporary increase in the number of cells with mitochondrial 
translocation of F-actin suggests F-actin transiently accumulates on mitochondria 
during mitochondrial toxin-mediated Drp1-dependent mitochondrial fission. 
Considering that the number of cells with F-actin positive mitochondria peaks at 2-5 
min, the cycling of F-actin between cytosol and mitochondria occurs before 
membrane scission events. Furthermore, the number of cells with mitochondrial 
positive F-actin increased at 2-5 min followed by a gradual decline regardless of the 
presence of functional Drp1, indicating that mitochondrial F-actin assembly and 





Subsection 3: de novo actin polymerization is required for mitochondrial fission 
We tested whether mitochondrial fission requires de novo actin 
polymerization. We utilized Latunculin B (LatB), an actin polymerization inhibitor, 
to prevent de novo F-actin assembly. Considering the toxicity of LatB, we treated the 
wild type MEFs with LatB for 32 min, then immunostained with cytochrome c and 
Alexa-Phalloidin. The data showed that LatB-treated wild type MEFs did not exhibit 
any unusual mitochondrial morphology (Fig. 2.10B). We also tested the degree to 
which LatB treatment could prevent stress-induced mitochondrial fission. Wild type 
MEFs were pretreated with LatB for 2 min, followed by the addition of Drp1-
dependent mitochondrial fission inducer FCCP for 30 min. After treatment, cells were 
immunostained with anti-cytochrome c mAb and Alexa-Phalloidin, followed by 
Figure 2.9 Quantitative analysis of the number of cells showing mitochondrial 
accumulation of F-actin. Wild type, Drp1-/-, Mff-/- and Mfn2-/- MEFs, as well as 
HeLa cells, were treated with FCCP or AntA as indicated in the figure followed by 
immunofluorescence and structured illumination imaging. Cells with 
mitochondrial F-actin were counted. Means ± average deviation (AvDev) of 
triplicate counting of 150 cells/condition are shown. 
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structured illumination imaging as well. Cells pretreated with LatB showed normal 
mitochondrial tubules, rather than mitochondrial fragmentation observed in FCCP 
only treated cells, suggesting that FCCP-induced mitochondrial fission was inhibited 
by LatB (Fig. 2.10C).  
We quantified the percentage of cells with different mitochondrial phenotypes 
in FCCP, AntA, LatB, LatB+FCCP, and LatB+AntA treated wild type MEFs. Cells 
with distinct mitochondria phenotype including tubular (white), fragmented (orange) 
and swollen (blue) were counted.  FCCP treatment induced a gradual increase of 
percentage of cells with fragmented mitochondrial from about 5% to about 70%, 
likewise AntA treatment led to about 45% of cells exhibiting fragmented 
mitochondria. While LatB did not affect mitochondrial phenotype after 30 min 
treatment, pretreatment of LatB followed by additional either 30 min FCCP or AntA 
dramatically decreased the percentage of cells with fragmented mitochondria (Fig. 
2.11). In sum, these data demonstrate that F-actin polymerization is required in the 




Figure 2.10 LatB pretreatment inhibited FCCP-induced mitochondrial 
fission. Wild type MEFs (A-C) were treated with FCCP for 30 min (A), LatB for 
32 min (B), or pretreated with LatB for 2 min, followed by addition of FCCP for 
additional 30 min (C). Cells were labeled with Alexa-Phalloidin to detect F-actin 
(red on overlay image) and immunostained with anti-cytochrome mAb (green on 
overlay image) to detect mitochondria. Bars: 20 µm; (detail) 5 µm. 
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Subsection 4: Mitochondrial assembly of F-actin in mitotic cells 
             Apart from stress-induced mitochondrial fission, the possibility that F-actin 
could also translocate to the mitochondria during physiological non-drug induced 
mitochondrial fission was also investigated. Interconnected mitochondrial networks 
become fragmented in mitotic cells in a Drp1-dependent manner, facilitating 
stochastic mitochondrial segregation into two daughter cells. To test whether 
mitochondrial accumulation of F-actin also occurs during mitosis, we utilized double 
thymidine block to synchronize cells in G1/S phase of the cell cycle. HeLa cells were 
treated with 2 mM thymidine for 18 hours, and then released to normal growth 
medium for 9 hours, followed by an additional 18 hours treatment of 2 mM thymidine 
to synchronize cells to G1/S checkpoint. Afterwards, cells were released into 
Figure 2.11 Quantitative analysis of mitochondrial morphological phenotypes 
in FCCP/AntA treated cells with LatB pretreatment. Wild type MEFs with 
indicated treatment for certain time points as indicated. Means ± AvDev from a 




thymidine-free medium to restart cell cycle progression, then fixed at different time 
points after release for up to 10 hours and immunostained with Alexa-Phalloidin, 
anti-cytochrome c mAb, and DAPI (4’6-diamidino-2-phenylindole) to detect DNA, 
followed by structured illumination imaging. Spatial relation of F-actin and 
mitochondria of cells in different stages of mitosis were analyzed. Cells in anaphase 
(Fig. 2.12A), in which chromosomes are split and the sister chromatids move to 
opposite poles of the cell, and prophase (Fig. 2.12B), in which chromatin condenses 
into chromosomes, revealed that F-actin probe Alexa-Phalloidin were aligned along 
mitochondrial labeled cytochrome c. Percentage of cells with mitochondrial F-actin 
(grey) and mitochondrial fragmentation (white) were calculated (Fig. 2.13). Although 
mitochondrial fragmentation was apparent in about 80% of metaphase cells and about 
85% of these cells showed mitochondrial association of F-actin cytoskeleton, 
mitochondrial assembly of F-actin was also detectable in about 95% of prophase 
cells, about 45% of which displayed mitochondrial fragmentation (Fig. 2.13). Thus, it 
appears that in a similar manner as in stress-induced mitochondrial fission, 





Figure 2.12. Spatial relations of F-actin and mitochondria in mitotic cells. 
HeLa cells were synchronized in G1/S phase of the cell cycle using a double 
thymidine block procedure and subsequently released into thymidine-free medium 
to restart the cell cycle progression. Cells were fixed at 8.5 hours after release and 
stained with anti-cytochrome c mAb (A and B overlay images; green; to reveal 
mitochondria), Alexa-Phalloidin (A and B overlay images; red; to reveal F-actin), 
and DAPI (A and B overlay images; blue, to reveal DNA), followed by structured 
illumination imaging. The examples of anaphase (A) and prophase (B) cells that 
were identified based on the chromosomal status and distribution are shown. 
Higher magnifications of insets marked with yellow rectangles in A and B are 
shown in detail images. Bar: 20 µm; (detail) 5 µm. 
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Subsection 5: Submitochondrial localization of F-actin 
In order the further characterize F-actin network colocalizing with the 
mitochondria, we examined the sub-mitochondrial localization of F-actin, in detail. 
Wild type, Drp1-/- and Mfn2-/- MEFs were treated with FCCP for 2 min, fixed and 
immunostained with Alexa-Phalloidin to detect F-actin and anti-cytochrome c mAb to 
detect mitochondrial intermembrane space, inner mitochondrial membrane (IMM) 
and mitochondrial cristae. Analyses of FCCP-treated wild type (Fig. 2.14A), Drp1-/- 
(Fig. 2.14C) and Mfn2-/- (Fig. 2.14E) revealed that F-actin did not colocalize with the 
cytochrome c-positive IMM, IMS or mitochondrial cristae, but rather formed 
Figure 2.13 Quantitative analysis of the number of cells with mitochondrial 
assembly of F-actin and mitochondrial morphology in mitotic progression. 
HeLa cells were synchronized in G1/S phase of the cell cycle using a double 
thymidine block procedure and subsequently released into thymidine-free medium 
to restart the cell cycle progression. Cells in different stages of mitosis were 
analyzed for mitochondrial F-actin and mitochondrial morphology. Data represent 
quantification of about 70 cells per mitotic stage. 
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cytochrome c circumscribing rings. These results were further confirmed by the 
fluorescence linescans analysis (Fig. 2.14B, D, F). Considering the patterns of F-actin 
colocalization with mitochondria are similar in wild type, Drp1-/- and Mfn2-/- MEFs, it 
appears that Drp1 does not affect F-actin distribution on mitochondria in FCCP-
induced mitochondrial fission model. Furthermore, immunofluorescence analysis and 
fluorescence linescans revealed that Alexa-Phalloidin colocalized with Tom20 (Fig. 
2.14G, H), further indicating that mitochondrial F-actin accumulates on the OMM. 
The OMM localization of F-actin points to a possible crosstalk between F-actin and 
OMM proteins during mitochondrial fission. 
            Drp1 and Mff are two essential mitochondrial fission factors. When Drp1 is 
activated, it is recruited to OMM through the integration with Mff, which acts as a 
Drp1 receptor on mitochondria (Otera et al. 2010). Mitochondrial Drp1 forms 
submitochondrial foci with Mff at prospective fission sites. Given the possibility that 
OMM-localized F-actin could interact with OMM-associated Drp1 and/or Mff, we 
analyzed the degree to which F-actin colocalized with these proteins Wild type MEFs 
were treated with FCCP for 2min, fixed and then immunostained with Alexa-
Phalloidin and anti-Drp1 or anti-Mff antibodies. While Drp1 and Mff formed 
submitochondrial foci, Alexa-Phalloidin revealed an equal F-actin distribution along 
the mitochondria with no specific colocalization with Drp1 and Mff (Fig. 2.15), 
suggesting that F-actin does not accumulate on Drp1/Mff positive mitochondrial 






Figure 2.14 Submitochondrial distribution of F-actin networks. Wild type 
(A), Mfn2-/- (C), and Drp1-/- (E and G) MEFs were treated with FCCP for 2 min, 
followed by immunostaining with Alexa-Phalloidin to detect F-actin (red on 




(Continued) space, mitochondrial inner membrane and mitochondrial cristae (A, 
C, E), or anti-Tom20 antibody to detect outer mitochondrial membrane (G) (green 
on overlay image). Higher magnifications of insets marked with yellow rectangle 
are shown in detail images. Linescans of fluorescence intensity are shown in B, D, 
F, H. Bar: 20 µm; (detail) 5 µm. 
Figure 2.15 F-actin did not form submitochondrial foci. Wild type (A) and 
Drp1-/- (B) MEFs were treated with FCCP for 2 min, fixed and immunostained 
with Alexa-Phalloidin (A and B) (red on overlay image), anti-Drp1 (A) or anti-Mff 
(B) antibodies (green on overlay image), followed by structured illumination 
imaging. Higher magnifications of insets marked with yellow rectangle are shown 
in detail images. Bar: 20 µm; (detail) 5 µm. 
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Subsection 6: Mitochondrial accumulation of F-actin in living cells 
To further verify mitochondrial assembly of F-actin independently, we 
utilized fluorescent actin probes and performed live cell time-lapse imaging. Lifeact 
is a 17 amino acids peptide derived from the N-terminal domain of actin binding 
protein 140 (Abp140), which specifically stained F-actin structures in eukaryotic cells 
and tissues. It has been shown that fluorescent protein-tagged Lifeact interacted with 
F-actin with about 30 times greater affinity than with G-actin, enabling visualization 
of local F-actin polymerization associated with various cellular pathways. Another 
benefit of Lifeact is that it does not interfere with actin dynamics in vitro and in vivo, 
which makes it an ideal tool to visualize F-actin cytoskeleton in live cell imaging 
(Riedl et al. 2008). HeLa cells cotransfected with mRuby-Lifeact and mito-YFP were 
treated with FCCP to induce mitochondrial fission, followed by time-lapse 
microscopy. These imaging experiments revealed that mitochondrial accumulation of 
mRuby-Lifeact was detectable at about 4 min, with a gradual decline in mitochondrial 
levels of mRuby-Lifeact at about 12 min after initial detection (Fig. 2.16 and 2.17). 
These data further confirmed the transient nature of the mitochondrial translocation of 
F-actin. Furthermore, the diffused OMM localization pattern of the mRuby-Lifeact 
(Fig. 2.18B) was reminiscent of that observed in Alexa-Phalloidin labeled fixed cells. 
Similar dynamics of F-actin assembly on the OMM was also detected in HeLa cells 
expressing dominant negative mutant Drp1K38A (Fig. 2.19, Fig. 2.20 and Fig. 2.21). 
Another live cell actin probe, the caplonin homology domain of utrophin (UtrCH), 
was also applied to further verify mitochondrial assembly of F-actin. UtrCH is able to 
bind specifically to F-actin without stabilizing it in in vitro dilution assays. It has been 
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shown that UtrCH interacted with F-actin in both fixed and living cells with no 
discernible effects on the actin cytoskeleton. HeLa cells cotransfected with mCherry-
UtrCH and mito-YFP were treated with FCCP followed by time-lapse imaging.  In a 
similar manner as mRuby-Lifeact, mCherry-UtrCH accumulated on the mitochondria 
in FCCP-treated cells at ~ 2-4 min after addition of FCCP and disappeared after 16 




Figure 2.16 Mitochondrial assembly of F-actin in living cells. HeLa cells 
expressing mRuby-Lifeact and mito-YFP were treated with FCCP as indicated, 
followed by a time-lapse structural illumination imaging. Fluorescence images of 
mRuby-Lifeact are shown. To enable easier interpretation of the data, fluorescent 
images were inverted. Arrows indicate F-actin-positive structures that are not 
altered by FCCP treatment. Bar: 20 µm; (detail) 5 µm. 
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 Figure 2.17 Mitochondrial assembly of F-actin in living cells (continued). 
HeLa cells expressing mRuby-Lifeact (red on the overlay image) and mito-YFP 
(green on the overlay image) were treated with FCCP as indicated, followed by a 






Figure 2.18 Mitochondrial assembly of F-actin in living cells (continued). 
HeLa cells expressing mRuby-Lifeact (red on the overlay image) and mito-YFP 
(green on the overlay image) were treated with FCCP as indicated, followed by a 
time-lapse structural illumination imaging. (A) Pseudocolored images showing the 
mitochondrial F-actin assembly at 0 min (green), 10 min (red), and 16 min (blue) 
after addition of FCCP within the red rectangle shown in Fig. 2.17. Arrows 
indicate F-actin-positive structures that are not altered by FCCP treatment, which 
shows a white pseudocolored signal. (B) Details from marked area in the image 
taken at 10 min of FCCP treatment. Bars: 5 µm. 
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 Figure 2.19 Mitochondrial assembly of F-actin in Drp1
K38A-expressing living 
cells. HeLa cells expressing Drp1K38A (determined by mitochondrial morphology), 
mRuby-Lifeact and mito-YFP were treated with FCCP as indicated, followed by a 
time-lapse structured illumination imaging. Fluorescence images of mRuby-
Lifeact are shown. To enable easier interpretation of the data, fluorescent images 




Figure 2.20 Mitochondrial assembly of F-actin in Drp1K38A-expressing living 
cells (continued). HeLa cells expressing Drp1K38A (determined by mitochondrial 
morphology), mRuby-Lifeact and mito-YFP were treated with FCCP as indicated, 
followed by a time-lapse structured illumination imaging. Fluorescence overlayed 





Figure 2.21 Mitochondrial assembly of F-actin in Drp1K38A-expressing living 
cells (continued). HeLa cells expressing Drp1K38A (determined by mitochondrial 
morphology), mRuby-Lifeact and mito-YFP were treated with FCCP as indicated, 
followed by a time-lapse structured illumination imaging. (A) Pseudocolored 
images showing the mitochondrial F-actin assembly at 0 min (green), 4 min (red), 
and 16 min (blue) after addition of FCCP within the rectangle area shown in Fig. 
2.20. (B) Details from marked area in the image taken at 4 min (shown in Fig. 




Figure 2.22 Mitochondrial assembly of mCherry-UtrCH in living cells. HeLa 
cells were transfected with mCherry-UtrCH (red on overlay images) and mito-YFP 
(green on overlay images) were treated with FCCP as indicated, followed by a 
time-lapse structured illumination imaging. (A) Fluorescence images of mito-YFP 
are shown. (B) Fluorescence images of mCherry-UtrCH are shown. To enable 
easier interpretation of the data, fluorescent images were inverted. (C) 
Fluorescence overlay images of mRuby-Lifeact and mito-YFP are shown. Bars: 20 





Section 4: Discussion 
            In this chapter, we show that transient assembly of F-actin on the OMM plays 
a vital role for the control of Drp1-driven mitochondrial division. F-actin 
polymerization occurs on the OMM upon mitochondrial uncoupler FCCP induced 
mitochondrial fission in a Drp1-independent manner. Clarifying the molecular 
mechanism that coordinates mitochondrial assembly of F-actin with Drp1-dependent 
events of mitochondrial fission is critical. Other than Mff, mitochondrial fission 
Figure 2.22 Mitochondrial assembly of mCherry-UtrCH in living HeLa cells 
(continued). HeLa cells expressing Drp1K38A (determined by mitochondrial 
morphology), mRuby-Lifeact and mito-YFP were treated with FCCP as indicated, 
folloed by a time-lapse structured illumination imaging. Detailed fluorescence 
images of the mitochondrial F-actin assembly at 0 min, 8 min, and 16 min after 
addition of FCCP within the rectangle area in Fig. 2.23 were shown. (B) Details 
from marked area in the image taken at 4 min (shown in Fig. 2.21) of FCCP 
treatment. Bars: 20 um; (detail) 5 um. 
Figure 2.23 Mitochondrial assembly of mCherry-UtrCH in living cells 
(continued). HeLa cells expressing Drp1K38A (determined by mitochondrial 
morphology), mRuby-Lifeact and mito-YFP were treated with FCCP as indicated, 
followed by a time-lapse structured illumination imaging. Detailed fluorescence 
images of the mitochondrial F-actin assembly at 0 min, 8 min, and 16 min after 
addition of FCCP within the rectangle area in Fig. 2.22 are shown. Bars: 20 µm; 
(detail) 5 µm. 
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proteins MiD49/51 directly recruit Drp1 to the mitochondrial surface and high level 
overexpression of MiD49/51 led to sequestering Drp1 from functioning at 
mitochondria, resulting in mitochondrial abnormal accumulation of inactive Drp1 and 
extensive mitochondrial tubules (Palmer et al. 2011b). These data suggest that 
overexpression of MiD49/51 does not impair the translocation of Drp1, but rather 
hinders Drp1 activity. In addition, high-level overexpression of MiD51 led to F-actin 
association with extensive mitochondrial tubules, further suggesting that 
mitochondrial F-actin disassembly coordinates with mitochondrial Drp1 activity. 
Supporting this notion, our data showed that F-actin accumulates on mitochondrial 
elongated tubules generated in cells expressing dysfunctional Drp1 or in the absence 
of Drp1. Together with previous reports, it is therefore plausible that mitochondrial F-
actin dynamics coordinate with Drp1, as well as Drp1 receptors such as Mff and 
MiD49/51.  
             As described previously, both fixed-cell and live-cell imaging exhibit a 
transient mitochondrial F-actin accumulation upon FCCP treatment. A temporal 
model of actin assembly during FCCP induced Drp1-dependent mitochondrial fission 
in mammalian cells similar to endocytosis is proposed based on our data. Clathrin-
mediated endocytosis is regulated by dynamin, which shares a similar domain 
organization and function with Drp1. In the early stage of endocytosis, clathrin and 
adaptors are recruited to the endocytic sites to initiate membrane curvature in the first 
1-2 min of the process. Afterwards, it takes about 15-25 seconds for the actin network 
and its nucleators to accumulate at the bud, then the invagination elongates, followed 
by dynamin recruitment and membrane fission (Mooren et al. 2012). In our study, we 
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found that F-actin polymerizes on mitochondria upon 2 min FCCP treatment, in a 
similar timeframe of actin network polymerization in endocytic sites. While the 
initiation of membrane curvature may not be dependent on actin according to EM 
studies, it is still unclear whether mitochondrial fission sites are determined and 
generated prior to actin polymerization. Upon initial polymerization, mitochondrial F-
actin patterns were presented for about 10 min before deploymerization, compared 
with only around 20 second of F-actin appearance at endocytic sites during clathrin-
mediated endocytosis. While a complete operation of clathrin-mediated endocytosis 
takes only a few minutes, the time duration of FCCP-induced mitochondrial fission 
process is usually 20-30 min.  This temporal deviation may be due to the size 
difference between cargo molecules and organelles. Actin may be needed for multiple 
stages in mammalian clathrin-mediated endocytosis, including invagination, tubule 
elongation and membrane fission. According to the time profiles of live-cell imaging 
and quantification of fixed-cell experiments, mitochondrial F-actin disassembles 
before the occurrence of Drp1 mediated membrane scission events, further suggesting 
that F-actin possibly assists Drp1 during tubules elongation and constriction, but not 
the final step of membrane fission. 
            The initiation of membrane curvature is sensed by BAR (Bin-Amphiphysin-
Rvs) domain superfamily proteins, which contains a highly conserved coil-coil 
protein dimerization domain and can be further categorized as BAR/N-BAR (N-
terminal amphipathic helix preceding the BAR domain) proteins, F-BAR (Fes/CIP4 
homology-BAR domain) proteins, and I-BAR (inverse BAR) proteins. During 
clathrin-mediated endocytosis in mammalian cells, BAR/N-BAR proteins are 
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recruited to invaginated buds and preferentially bind to highly curved membranes and 
induce curvature in cells to promote and stabilize tubulation (Frost et al. 2009). In 
addition, BAR/N-BAR proteins also stimulate Arp2/3-mediated actin network 
assembly at endocytotic sites. Synaptic enriched BAR-domain containing protein 
Tuba is able to bind to dynamin, as well as various actin regulatory protein including 
N-WASP and Ena/VASP and promotes actin assembly through the C-terminal SH3 
domain. Another major binding partner of dynamin SNX9 was also reported to 
directly regulate F-actin nucleation through N-WASP and the Arp2/3 complex and 
couples actin assembly to phosphoinositide signals in membrane remodeling during 
endocytosis (Ferguson et al. 2009). Although several BAR domain proteins have been 
reported to be involved in clathrin-mediated endocytosis, only one BAR domain 
protein called endophilin B1 is required for the maintenance of mitochondrial 
morphology. Downregulation of endophilin B1 or overexpression of endophilin B1 
lacking the NH2 terminal lipid-modifying domain alters mitochondrial morphology 
and distribution. Cytosolic endophilin B1 also translocates to the mitochondria during 
apoptosis stimuli induced membrane remodeling (Karbowski, Jeong, et al. 2004). 
Considering the role of BAR-domain proteins in stimulating actin assembly in 
endocytosis, it is possible that endophilin B1 senses the membrane curvature and 
subsequently initiate actin polymerization on mitochondria in the very early stage of 
mitochondrial fission. Double knockdown of endophilin B1 and Drp1 leads to 
mitochondrial elongation that is identical to Drp1 single knockdown suggesting that 
Drp1 acts upstream of endophilin B1 (Karbowski, Jeong, et al. 2004), which can be 
explained by the dual function of BAR-domain proteins during membrane remodeling. 
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Quantitative analysis of the time profiles for protein recruitment of various proteins 
revealed that an F-BAR protein FBP17 showed biphasic recruitment and peaked after 
scission (Mooren et al. 2012), supporting the notion that Drp1 works upstream of 
endophilin B1 during mitochondrial fission. Considering that BAR domain proteins 
are able to interact with dynamin and actin regulatory protein N-WASP and the 
biphasic recruitment profiles, it appears that in mammalian cells BAR-domain 
proteins contributes to membrane scission beyond initiating membrane curvature. 
            Mitochondrial membrane constriction and scission during fission occurs 
through Drp1-dependent oligomerization and GTP hydrolysis (Ingerman et al. 2005). 
However, how transient F-actin assembly on the mitochondria contributes to 
mitochondrial fission is still unclear. Biochemical interactions between dynamin and 
actin cytoskeleton are mediated by actin binding proteins, as well as BAR domain 
proteins (Gu et al. 2010a; Gu et al. 2014), suggesting that dynamin may couple the 
actin network to mitochondrial fission. One possible mechanism is that actin 
cytoskeleton may contribute to membrane constriction and scission. Stalled clathrin 
pits resulting from actin inhibitors did not recruit dynamin, implying that actin may 
generate membrane tension to assist dynamin mediated membrane constriction. 
Further supporting this notion, a role of myosin II in mammalian mitochondrial 
fission has been reported (Korobova et al. 2014b). Pharmacological inhibition or 
downregulation of actin motor protein Myosin II increased mitochondrial length in 
U2OS cells and decreased mitochondrial associated Drp1. Immunofluorescence 
analysis revealed that Myosin II was present at mitochondrial constriction sites. 
Considering that Myosin II functions to generate powerful contractile forces, these 
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data indirectly point to a role of actin and myosin II in assisting Drp1-driven 
membrane constriction. In addition, myosin I and VI were recruited to sites of 
clathrin-mediated endocytosis as part of the dynamin module (Geli et al. 1998; 
Kirchhausen et al. 2014), providing further evidence that actin cytoskeleton may 
assist dynamin mediated membrane constriction and subsequent scission by myosin 
generated force. Furthermore, FRET analysis revealed that dynamin oligomerization 
was inhibited by pharmacological inhibition of actin polymerization (Ferguson & De 
Camilli 2012), suggesting that mitochondrial actin network polymerization may also 
promote Drp1 polymerization during fission processes. 
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Chapter 3: Actin-modifying proteins contributes to Actin 
cytoskeleton-dependent mitochondrial fission 
Publication: Sunan Li, Shan Xu, Brian A. Roelofs, Liron Boyman, W. Jonathan 
Lederer, Hiromi Sesaki, and Mariusz Karbowski. Transient assembly of F-actin on 
the outer mitochondrial membrane contributes to mitochondrial fission. 2015. 208(1): 
109-123. 
 
Section 1: Introduction 
F-actin polymerization requires the appropriate function of actin nucleating 
proteins. Based on the structure of actin filaments, actin nucleating proteins fall into 
three main categories: (1) Arp2/3 complex and nucleating promoting factors (NPFs), 
(2) tandem monomer binding nucleators and (3) formins (Campellone & Welch 
2010). Arp2/3 complex consists of actin-related proteins Arp2 and Arp3 and five 
additional subunits ARPC1-5. Arp2/3 complex activation requires both the binding to 
the sides of mother actin filaments and NPFs, featuring both G-actin binding WH2 
and Arp2/3 complex binding domains. Upon activation, Arp2/3 complex creates a 
new nucleation core and grows newly synthesized actin filaments on the old ones to 
form a functional branched actin network (Rotty et al. 2013). Tandem-monomer-
binding nucleators, a recently identified group including Spire, Cordon-bleu (Cobl), 
Leiomodin (Lmod-2), JMY and andenomatous polyposis coli (APC), possess tandem 
repeats of G-actin binding motifs. These nucleators bring G-actin monomer together 
to form a polymerization nucleus and stabilize either the actin-monomers along the 
long-pitch helix or cross-filament interactions along the short-helix of actin filament 
(Firat-Karalar & Welch 2011). Formins are multi-domain proteins that dimerize to 
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nucleate and elongate actin filaments. Formins bear conserved formin homology 1 
(FH1) and FH2 domains. The homodimeric FH2 domain forms a ring structure to 
catalyze actin nucleation by stabilizing actin dimers. The proline-rich linear FH1 
domain stimulates the elongation of actin filaments by binding to profilin-bound G-
actin and deliver it to the barbed end (Zigmond 2004).  
          Arp2/3 complex and NPFs are the major actin nucleators found at endocytosis 
sites and various other membrane trafficking events (Mooren et al. 2012; Lanzetti 
2007; Grassart et al. 2014). The Arp2/3 complex is the key regulator for actin 
filament assembly at endocytic sites in yeast and mammalian cells. Loss of WASp 
inhibits endocytosis and reduces the frequency at which actin accumulates at sites of 
endocytosis (Benesch et al. 2005), suggesting that activation of Arp2/3 complex at 
endocytic sites requires the presence of Class I NPF WASp. Class II NPF cortactin 
binds to the Arp2/3 complex via SH3 domain and actin via tandem cortactin repeats, 
in order to stabilize Arp2/3 dependent actin filament branching and promote actin 
filaments growth in clathrin-mediated endocytosis (Weaver et al. 2002). Cortactin can 
also interact with dynamin via a proline-rich region, serving as a bridge between actin 
cytoskeleton and the dynamin superfamily (Zhu et al. 2005). In addition, coronin 
family proteins are known to directly inhibit the Arp2/3 complex in vitro and 
synergize with cofilin to promote actin severing and disassembly (Cai et al. 2007). 
Cofilin-mediated severing provides positive ends on filament fragments, subsequently 
destabilizes the filament and preferentially promotes the release of ADP-actin 
monomer, further enhancing the dynamics of actin filament assembly as a long-
lasting effect (De La Cruz 2009). 
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          In the previous chapter, I discussed results supporting the role of transient F-
actin assembly on the OMM in Drp1-mediated mitochondrial fission. However, the 
mechanism of mitochondrial F-actin assembly still remains unclear. In this chapter, I 
will discuss the evidence that FCCP-induced mitochondrial F-actin polymerization on 
the OMM is mediated by Arp2/3 complex and Class II NPF cortactin and actin 
severing protein cofilin.  
Section 2: Materials and Methods 
Subsection 1: Cell culture 
            HeLa cells, wild type mouse embryonic fibroblasts (MEFs), and Drp1-/- MEFs 
were provided by Dr. H. Sesaki from Johns Hopkins University (Wakabayashi et al. 
2009). HeLa cells and MEFs were cultured in DMEM supplemented with 10% heat-
inactivated fetal bovine serum, 2 mM Glutamax, 1 mM sodium pyruvate, 1 mM 
nonessential amino acids, 100 U/ml penicillin in 5% CO2 at 37°C.  
Subsection 2: General experimental methods 
Transfection, immunofluorescence, image acquisition and live cell imaging 
were performed as described in Chapter 2 (section 2 Materials and Methods). 
Subsection 3: Expression constructs and shRNA 
GFP-tagged INF2 and INF2A149D were provided by H. Higgs (Dartmouth 
Medical School, Hanover, NH) (Korobova et al. 2013). MISSION shRNAi vectors 
were purchased from Sigma-Aldrich. Cortactin (TRCN0000294181, RNAi#1; 
TRCN0000294182, RNAi#2; and TRCN0000298256, RNAi#3), cofilin 
 74 
 
(TRCN0000381606, RNAi#1; TRCN0000381418, RNAi#2; and TRCN0000381720, 
RNAi#3), gelsolin (TRCN0000343442, RNAi#1; TRCN0000343443, RNAi#2; and 
TRCN0000352869, RNAi#3), Arp2 (TRCN0000290833), p34 (TRCN0000379644), 
Opa1 (TRCN0000303506), and Mfn2 (TRCN0000082686) were downregulated with 
above-mentioned MISSION shRNAi vectors. eGFP targeting shRNAi construct was 
used as a control (SHC005). Cells were transfected with respective shRNAi 
constructs, and then 24 hours after transfection they were incubated with 3 µg/ml 
puromycin for an additional 4-5 days to select for transfected cells. 
Subsection 4: Mitochondrial fusion assay 
Mitochondrial matrix-targeted photoactivatable GFP (Mito-PAGFP)-based 
mitochondrial fusion assay was performed using a confocal microscope (LSM 510 
META; Carl Zeiss) equipped with Plan-Apochromat 100x/1.4D oil DIC M27 
objective lens (Carl Zeiss) as described previously (Karbowski, Arnoult, et al. 2004; 
Karbowski et al. 2006). Cells were transfected with mito-PAGFP for 18 hours, then 
incubated in Phenol-Red DMEM. In brief, after acquisition of a preactivation image, 
a 5-µm-diameter circular region of interest (ROI) was photoactivated by brief 
irradiation with 351/364-nm light (using Coherent Enterprise Ion Laser 80.0mW), 
followed by time-lapse imaging using 488-nm Argon Ion Laser excitation (25.0 mW 
set at 0.3%). 15 postactivation images were collected with the interval between 
images set to 2 min. To avoid z-section shift, focus was maintained using the “Multi-
time Macro” and the autofocusing system (utilizing linescans to detect the reflection 
off the coverglass). Images were acquired and analyzed using ZEN 2009 image 
acquisition software (Carl Zeiss).  
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The diffusion rates of mito-PAGFP are likely to be similar to mito-GFP 
diffusion coefficients of 2-3 × 10-7 cm2/s determined by spot photobleaching, which is 
only three- to fourfold less than that for GFP diffusion in water (Partikian et al. 1998). 
Due to the fast diffusion of GFP within the mitochondrial matrix, photoactivated 
PAGFP rapidly diffuses from the activated ROIs. The redistribution and dilution of 
mito-PAGFP fluorescence from the matrix of “photoactivated” mitochondria into 
nonactivated mitochondria that occurs as a result of mitochondrial membrane fusion 
is used to monitor and quantify this process. Images were analyzed by using region 
measurement tool to collect pixel intensities within activated ROIs as well as in 
nonactivated areas of the cell from all images in the series. The obtained values can 
then be plotted as a function of time (Karbowski et al. 2014). 
Subsection 5: Western blot 
Cells were harvested, and total cell protein lysates were prepared as 
previously described (Xu et al. 2011). In brief, cells were washed with ice-cold PBS, 
collected by scrapping, then centrifuged at 0.8rcf for 5 min. Cell pellets were 
resuspended in 1x SDS PAGE sample buffer, and incubated at 100°C for 10 min. 
Protein concentrations were measured directly in the samples using NanoDrop 1000 
spectrophotometer (Thermo Fisher Scientific). Proteins were separated on 4–20% 
gradient Tris-Glycine polyacrylamide gels (Invitrogen) at 150 volts for 90 min, 
transferred onto PVDF membranes (Immubilon-P; Millipore) at 100 volts for 90 min. 
Blots were blocked with 5% milk in PBS-Tween for 1 hr, incubated with primary 
antibodies overnight, then washed 3 times with Tween-PBS for 20 min, followed by 
HRP-conjugated anti–mouse (1:2000; Roche) or anti–rabbit (1:5000; Roche) 
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secondary antibodies. Before detection, blots were washed 2 times with Tween-PBS 
for 20 min and 1 time with PBS for 20 min, and then detected with SuperSignal West 
Pico Chemiluminescent Substrate (Life Technologies) using ImageQuant LAS4000 
chemiluminescence imager (GE Healthcare). Antibodies used for Western blot were: 
anti-cortactin mAb (1:1000; BD Biosciences), anti-cofilin polyclonal antibody 
(1:1000; clone FL-166; Santa Cruz Biotechnology, Inc.), anti-Arp2 polyclonal 
antibody (1:500; clone H-84; Santa Cruz Biotechnology, Inc.), anti-ARC/p34 
polyclonal antibody (1:1000; Millipore), anti-Tom20 polyclonal antibody (1:5000; 
clone FL-145; Santa Cruz), anti-Opa1 monoclonal antibody (1:1000; BD 




Section 3: Results 
Subsection 1: Knockdown of actin-modifying proteins resulted in abnormal 
mitochondrial elongation 
To further determine the mechanism of F-actin participating in mitochondrial 
division, we sought to determine whether actin-regulatory proteins could also regulate 
the mitochondrial fission process via modifying actin filaments.  In order to achieve 
this, we analyzed the degree to which overexpression or downregulation of a broad 
range of proteins regulating F-actin nucleation, stabilization and disassembly, 
including WASp, Arp2/3 complex, gelsolin, cofilin, Abp1, cortactin, formin1, 
FBP17, coronin, affect mitochondrial network organization (Table 3.1). This 
selection was based on the established role for each of these factors in the regulation 
of actin cytoskeleton in membrane trafficking in cellular compartments other than 
mitochondria, including clathrin-dependent and -independent endocytosis (Mooren et 
al. 2012; Römer et al. 2010; Egea et al. 2006; Shivas & Skop 2012; Anitei & Hoflack 
2012). While overexpression of any of the above-mentioned proteins did not affect 
mitochondrial network organization, downregulation of Arp2/3 complex, cortactin 
and cofilin led to dramatic elongation and interconnection of mitochondria, as 
compared with control RNAi cells (Fig. 3.2 and Fig. 3.4). 
            First, we investigated the effect of Arp2/3 complex depletion on 
mitochondrial morphology. As described before, Arp2/3 complex is a seven-subunit 
protein complex that plays a major role in nucleating branched F-actin cytoskeleton. 
It consists of actin-related proteins Arp2 and Arp3, p20, p21, p34 and p40. Arp2 and 
Arp3 closely resemble the structure of monomeric actin and serve as nucleation sties 
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for actin filaments (Rotty et al. 2013). To knockdown Arp2/3 complex, HeLa cells 
were transfected with (1) single Arp2 shRNA (achieved by a mix of two Arp2 shRNA 
constructs), (2) single ARC or p34 shRNA (achieved by a mix of two ARC or p34 
constructs) and (3) double Arp2/p34 shRNA (achieved by one independent construct 
for each target), followed by 4 days puromycin selection before collecting cell 
lysates. Cells were harvested and cell lysates were subjected to SDS-PAGE followed 
by Western blotting. Western blots of total cell lysates showed that Arp2 and p34 
were successfully downregulated in both single and double shRNAi cells (Fig. 3.1). 
Notably, single shRNA of Arp2 also reduced the expression level of p34 and vice 
versa. It appears that downregulation of Arp2 and/or p34 was able to decrease other 
subunits of Arp2/3 complex, leading to a complete knockdown of Arp2/3 complex. 
To explore the effect of Arp2/3 complex downregulation on mitochondrial 
morphology, we immunostained Arp2/3 shRNA cells with anti-cytochrome c mAb to 
reveal mitochondrial structure. Compared to control shRNA cells, 
immunofluorescence analysis displayed abnormal elongated mitochondrial tubules in 
cells with reduced Arp2/3 complex expression level (Fig. 3.2). Quantitative analysis 
also exhibited an increase in the percentage of cells with elongated mitochondria in 
Arp2/3 complex shRNA cells. While there were only 5% of cells with an 
interconnected network in control shRNA cells, about 40% of cells showed 
mitochondrial interconnection in Arp2/3 complex shRNA cells, suggesting that 
mitochondrial division may be impaired by reduction of Arp2/3 complex (Fig. 3.5). 
In addition, given that Arp2/3 complex binds to the sides of existing filaments and 
specifically initiates branched actin network, which grows a distinctive new filament 
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at a 70-degree angle from the mother filament, these data may point to a role of 
branched F-actin polymerization in mitochondrial fission. 
   Table 3.1 Selection of actin-modifying proteins. 
            Other than Arp2/3 complex, downregulation of cortactin or cofilin, two actin 
regulatory proteins, also affects mitochondrial network organization. Cortactin, a 
class II nucleating promoting factor, is an essential molecule promoting and 
stabilizing Arp2/3 complex mediating branched F-actin polymerization, as well as 




WASp Activate Arp2/3 complex; stimulate 
branched F-actin polymerization 




Consists of APRC1-5, Arp2 and Apr3; 
branched actin nucleation 
Vari
ed 
(Rotty et al. 
2013) 
cortactin Recruit Arp2/3 complex to existing actin; 
facilitating and stabilizing nucleation 
85 (Uruno et al. 
2001) 
cofilin Disassemble F-actin; sever F-actin without 
capping and prefer ADP-actin 
19 (Pavlov et al. 
2007) 
gelsolin Sever and cap F-actin in a Ca2+, pH and 
phospholipid dependent manner 
86 (Méré et al. 
2005) 
formin1 Promote non-branch F-actin nucleation and 
bundling 
184 (Kobielak et al. 
2004) 
FBP17 Link formin and dynamin; recruit actin 
regulatory proteins 
71 (Tsuboi et al. 
2009) 
Abp1 Functionally link the actin cytoskeleton to 
dynamin 
65 (Kessels et al. 
2001) 
coronin Coordinate Arp2/3 mediated actin branches 
and cofilin activity 




scaffold has an N-terminal acidic domain that binds and stabilizes Arp2/3 complex, 
six tandem repeats segments in the central region that directly bind to F-actin, a C-
terminal SH3 domain that interacts with the proline-rich domain of WASp and 
dynamin, indicating that cortactin is likely engaged in F-actin participated Drp1-
mediated mitochondrial fission process (Orth & McNiven 2003). To test this 
hypothesis, HeLa cells were transfected with three independent cortactin  targeting 
shRNA constructs, selected by puromycin for 4 days, then analyzed by Western blot. 
Western blot results showed successfully knockdown of cortactin in all three shRNAi 
cells (Fig. 3.3). Cortactin shRNAi cells were analyzed by immunofluorescence. 
Mitochondrial tubules were extensively elongated and interconnected in cortactin 
shRNAi cells, as compared to control shRNAi cells (Fig. 3.4A and B), and the 
percentage of cells with elongated mitochondria was increased in cortactin shRNA 
Figure 3.1 Downregulation of Arp2/3 complex in HeLa cells. HeLa cells were 
transfected with control shRNA (lane 1), Arp2 shRNA (lane 2), ARC/p34 shRNA 
(lane 3) and double Arp2 and ARC/p34 shRNA (lane 4), then selected by 
puromycin. Total cell lysates collected from respective shRNA samples were 
analyzed by Western blotting, blotted with anti-Arp2, anti-p34 and anti-Tom20 
antibodies as loading control. 
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cells as well (Fig. 3.5), suggesting that reduction of cortactin creates conditions 
supporting mitochondrial elongation. During clathrin-mediated endocytosis, cortactin, 
together with actin and Arp2/3 complex, are recruited to clathrin-coated pits at the 
late-phase of dynamin recruitment, in synchrony with endocytic buds invagination. 
My data implies that cortactin may serve as a mitochondrial F-actin regulatory factor 
along with Arp2/3 complex in mitochondrial fission. Considering that cortactin 
recruits and stabilizes Arp2/3 complex, promoting actin filaments extension, the 
possibility that cortactin stimulates mitochondrial fission by enhancing and stabilizing 
Arp2/3 complex mediated branched F-actin polymerization is also likely. 
The role of cofilin, an actin binding protein to sever and dissemble actin 
filaments during cellular membrane ruffling, in mitochondrial fission was also 
examined. As a member of the ADF/cofilin family, cofilin binds to both actin 
monomers and filaments to reorganize actin filaments. Cofilin depolymerizes actin 
filaments by two major activities: 1) severing that dissociates G-actin-ADP from the 
minus end of actin filaments, creating free barbed ends for further polymerization, 2) 
preventing actin monomers from binding to the pointed end, in order to maintain G-
actin/F-actin cycles and promote actin polymerization in long-term effect (Pavlov et 
al. 2007). To clarify the role of cofilin in mitochondrial dynamics, HeLa cells were 
transfected with three independent cofilin targeting shRNA constructs, selected by 
puromycin for 4 days, then analyzed by Western blot. Western blot results showed 
cofilin expression was downregulated in all three shRNA constructs transfected cells 
compared with control shRNA cells (Fig. 3.3). Cells with reduced cofilin expression 
levels were analyzed by immunofluorescence. In contrast to control shRNA cells, the 
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mitochondrial network was extensively elongated in cofilin shRNA cells (Fig. 3.4A 
and C), and percentage of cells with mitochondrial elongation was increased (Fig. 
3.5), suggesting that reduction of cofilin induces mitochondrial elongation. Although 
cofilin disassembles actin filaments to create free barbed ends, the prolonged 
Figure 3.2 Downregulation of Arp2/3 complex resulted in abnormal 
mitochondrial elongation. HeLa cells were transfected with (A) control shRNA, 
(B) Arp2 shRNA (achieved by a mix of two independent Arp2 targeting shRNA), 
(C) ARC/p34 shRNA (achieved by a mix of two independent ARC/p34 targeting 
shRNA), and (D) Arp2+ARC/p34 shRNA (achieved by one shRNA construct per 
each target), selected by puromycin, then fixed and immunostained with anti-
cytochrome c mAb to detect mitochondria followed by structured illumination 
imaging. Higher magnifications of area marked with yellow rectangles are shown 
in detail images. Bars: 20 µm; (detail) 5 µm. 
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mitochondrial tubules can be explained by the long-term effect of cofilin, which 
promotes F-actin assembly by providing free G-actin monomers for further nucleation 
and polymerization.  
 
In addition, the effect of another major actin-severing protein gelsolin on 
mitochondrial morphology was also analyzed. Quantative analysis of 
immunofluorescence of gelsolin shRNA cells (obtained by three independent gelsolin 
targeting shRNA constructs) revealed that the percentage of cells with elongated 
mitochondrial tubules was not altered by the reduction of gelsolin (Fig. 3.5), 
Figure 3.3 Downregulation of cortactin and cofilin in HeLa cells. HeLa cells 
were transfected with control shRNA (A and B), cortactin shRNA (3 independent 
cortactin targeting shRNA constructs) (A), cofilin shRNA (3 independent cofilin 
targeting shRNA constructs) (B), selected by puromycin and subjected to Western 
blot by anti-cortactin, anti-cofilin and anti-Tom20 antibodies as loading control. 
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suggesting that gelsolin expression level is not related to mitochondrial morphology. 
These results further support the specificity of the role of Arp2/3 complex, cortactin 
and cofilin in mitochondrial morphological dynamics, supporting the notion that 
mitochondrial elongation is induced by the downregulation of Arp2/3 complex, 
cortactin and cofilin, rather than the cascade signaling effect of impaired actin 
filaments network in the whole cells. Given the role of Arp2/3 complex, cortactin and 
cofilin contributing to actin filaments assembly, it is likely that Arp2/3 complex 
synergizes with cortactin and cofilin to coordinate the mitochondrial specific actin 
network stimulating mitochondrial division.  
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 Figure 3.4 Downregulation of cortactin and cofilin resulted in abnormal 
mitochondrial elongation. HeLa cells were transfected with control shRNA (A), 
cortactin shRNA (3 independent cortactin targeting shRNA constructs) (B), cofilin 
shRNA (3 independent cofilin targeting shRNA constructs) (C), selected by 
puromycin, then fixed and immunostained with anti-cytochrome c mAb to reveal 
mitochondria. Higher magnifications of areas marked with yellow rectangles are 
shown in detail images. Bars: 20 µm; (detail) 5 µm. 
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Subsection 2: Actin-modifying proteins are required for mitochondrial fission 
            In the previous section, out data showed that knockdown of actin-modifying 
proteins including Arp2/3 complex, cortactin and cofilin resulted in mitochondrial 
elongation, supporting of the possibility that these proteins control the mitochondrial 
fission process. Hereby, in order to depict the role of F-actin polymerization in the 
mechanism of mitochondrial fission, we analyzed whether cortactin or cofilin 
reduction was able to prevent FCCP induced Drp1-dependent mitochondrial division. 
To this end, HeLa cells were transfected with control shRNA, cortactin shRNA and 
Figure 3.5 Quantitative analysis of mitochondrial morphological phenotype in 
actin regulatory proteins shRNA cells. HeLa cells were transfected with control 
shRNA, cortactin shRNA, cofilin shRNA, Arp2 and/or p34 shRNA and gelsolin 
shRNA, selected by puromycin, fixed and immunostained with anti-cytochrome c 
mAb as described before, and then quantified as indicated in the figure. Data 
represent mean ±	 AvDev from a representative experiment after triplicate 
counting of 150 cells/condition. Values for the control shRNA cells were obtained 
by averaging two triplicate counts of 150 cells /condition obtained independently 
in cortactin/cofilin and Arp2/p34 shRNA experiments. Mitochondrial morphology 
in gelsolin shRNA cells was also quantified in a similar manner. 
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cofilin shRNA constructs, selected by puromycin for 4 days, treated with FCCP for 
30 min before fixation, and then immunostained with anti-cytochrome c mAb. While 
in control shRNA cells, 30 min of FCCP treatment induced mitochondrial 
fragmentation (Fig. 3.6A and B), immunofluorescence and quantitative analysis 
showed that mitochondria remained interconnected after 30 min FCCP treatment in 
cortactin shRNA cells and to a lesser degree cofilin shRNA cells (Fig 3.6C and D, 
and Fig. 3.7), indicating that downregulation of cortactin and cofilin expression levels 
prevented FCCP-induced mitochondrial fragmentation. Thus, these data indicate that 
FCCP-induced mitochondrial fission is prevented by reduced cortactin and cofilin, 
suggesting that these actin-modifying proteins are required for FCCP-induced 




Figure 3.6 Downregulation of cortactin prevented FCCP-induced 
mitochondrial fragmentation. HeLa cells were transfected with cortactin 
shRNA, selected by puromycin, then treated with DMSO or 10 uM FCCP before 
fixation. Cells were then immunostained with anti-cytochrome c mAb to reveal 
mitochondrial structure. Higher magnifications of areas marked with yellow 













Figure 3.7 Quantitative analysis of mitochondrial morphological phenotype in 
FCCP-treated cortactin and cofilin shRNA cells. HeLa cells were transfected 
with control shRNA, cortactin shRNA and cofilin shRNA, selected by puromycin, 
then treated with FCCP for 30 min before fixation, and immunostained by anti-
cytochrome c mAb and quantified as indicated in the figure. Data represent mean 






To further explore the role of actin-modifying proteins cortactin and cofilin in 
mitochondrial fission, we also examined whether cortactin and cofilin controls non-
FCCP induced mitochondrial division. Mfn2 and Opa1 are two essential 
mitochondrial fusion factors (see chapter 1 for details). Reduction of either Mfn2 or 
Figure 3.8 Cortactin downregulation restored mitochondrial fragmentation 
induced by reduced Mfn2 expression. HeLa cells were transfected with control 
shRNA(A), Mfn2 shRNA(B), Opa1 shRNA(C), cortactin shRNA(D), 
Mfn2/cortactin shRNA (E) and Opa1/cortactin shRNA (F), selected by puromycin, 
fixed and immunostained with anti-cytochrome c mAb to detect mitochondrial 
structure, followed by structured illumination imaging. Higher magnifications of 
areas marked with yellow rectangles are shown in detail images. Bars: 20 µm; 
(detail) 5 µm. 
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Opa1 expression level led to formation of fragmented mitochondria networks as 
shown in Fig. 3.8B, C and Fig. 3.9, resulting from the inhibition of fusion activity. In 
order to analyze if cortactin and/or cofilin knockdown can also reverse the 
mitochondrial fragmentation in Mfn2 and Opa1 knockdown cells, HeLa cells were 
cotransfected with either cortactin/Mfn2 or cortactin/Opa1 shRNA constructs, 
selected by puromycin, fixed and immunostained with anti-cytochrome c mAb. 
Notably, downregulation of Mfn2 alone led to formation of fragmented mitochondrial 
networks in 76.7 ± 3.9% of the cells (Fig. 3.8B and Fig. 3.9), while cortactin/Mfn2 
double shRNA displayed mitochondrial fragmentation in only 18.2 ± 3.8% of the 
Figure 3.9 Quantitative analysis of mitochondrial morphological phenotype in 
cortactin/Mfn2 and cortactin/Opa1 double shRNA cells. HeLa cells were 
transfected with control shRNA, Mfn2 shRNA, Opa1 shRNA, cortactin shRNA, 
Mfn2/cortactin shRNA and Opa1/cortactin shRNA, selected by puromycin, fixed 
and immunostained with anti-cytochrome c to detect mitochondria, followed by 
structured illumination imaging. Mitochondrial morphologies were quantified as 
indicated in the figure. Data represent mean ± AvDev from a representative 
experiment after triplicate counting of 150 cells/condition. 
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cells (Fig. 3.8E and Fig.3.9). Furthermore, there was no detectable effect of cortactin 
shRNA on mitochondrial fragmentation induced by downregulation of Opa1 (Fig. 
3.8C, F and Fig. 3.9). Considering that Mfn2 depletion results in partial inhibition of 
mitochondrial fusion, it is likely that restoration of mitochondrial tubules observed in 
cortactin/Mfn2 double shRNA cells is due to the compensation of Mfn1-dependent 
mitochondrial fusion activity. The failure to rescue mitochondrial fragmentation 
induced by Opa1 could be explained by the complete fusion inhibition caused by loss 
of Opa1. Western blot analysis confirmed an efficient knockdown of cortactin, Mfn2 
and Opa1 expression level (Fig. 3.10). In sum, these results indicate that reduction of 
cortactin and/or cofilin reverse both FCCP- and Mfn2 depletion-induced 
mitochondrial fragmentation, further supporting roles for cortactin and cofilin in 
mitochondrial fission. 
 
Figure 3.10 Protein expression levels in cortactin, cortactin/Mfn2, and 
cortactin/Opa1 shRNA cells. HeLa cells were transfected with control shRNA, 
Mfn2 shRNA, Opa1 shRNA, cortactin shRNA, Mfn2/cortactin shRNA and 
Opa1/cortactin shRNA, selected by puromycin, harvested and subjected to 
Western blot analysis. Blots were immunolabeled with anti-cortactin, anti-Mfn2, 
anti-Opa1 and anti-Tom20 antibodies as loading control. 
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Mitochondrial elongation and interconnection are induced not by inhibition of 
mitochondrial division, but rather through the activation of mitochondrial fusion in a 
process called SIMH (Stress-induced Mitochondrial Hyperfusion) (Tondera et al. 
2009). To examine whether the extensive mitochondrial tubules induced by 
Figure 3.11 Quantitative analysis of mitochondrial fluorescence intensities in 
control, cortactin, cofilin and Arp2/3 complex shRNA cells. (A) Control 
shRNA, cortactin shRNA, cofilin shRNA and Arp2 shRNA cells were quantified 
and plotted as a function of time as shown in the figure. Initial postactivation 
values were normalized to 100%. Data represent mean ± AvDev of 32 (control 
shRNA), 21 (cortactin shRNA), 24 (cofilin shRNA), and 14 (Arp2 shRNA) single 
cell time-lapse experiments. (B) mito-PAGFP fluorescence intensity and p-value 
of indicated time are shown. 
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downregulation of cortactin and cofilin is caused by increased fusion activity, we 
further analyzed the mitochondrial fusion rates in Arp2/3 complex shRNA, cortactin 
shRNA and cofilin shRNA cells. To achieve this, we applied a mitochondrial matrix-
targeted photoactivatable GFP (mito-PAGFP)-based mitochondrial fusion assay. 
HeLa cells were transfected with control shRNA, cortactin shRNA, cofilin shRNA 
and Arp2 shRNA, selected by puromycin for 4 days, then transfected with mito-
PAGFP for 18 hours. After transfection, regions of interest (red circles in 
preactivation; “Pre” images in Fig. 3.12A and B) in mito-PAGFP-expressing control, 
cortactin, cofilin and Arp2+ARC/p34 shRNA cells were photoactivated by brief 
irradiation with UV light, followed by time-lapse imaging with 488-nm light every 
about 2 min, over about 30 min. After mito-PAGFP signal is activated by UV light, 
the rates of fluorescence signal decreases over time reflect mitochondrial fusion rates 
as higher mitochondrial fusion activity accelerates the spreading of fluorescence 
molecules. The profiles of fluorescence images revealed that mito-PAGFP signals 
decreased in control shRNA and cortactin shRNA cells at a similar time frame. 
Supporting this notion, quantification of mito-PAGFP fluorescence changes in several 
time-lapse experiments revealed similar fusion rates in all analyzed cell groups (Fig. 
3.11). These data further support the possibility that it is not induction of 
mitochondrial fusion, but rather inhibition of mitochondrial fission that induced the 
mitochondrial elongation and interconnection observed in Arp2/3 complex, cortactin 








Figure 3.12 Times-lapse series of mito-PAGFP-based mitochondrial fusion 
assay in control and cortactin shRNA cells. HeLa cells were transfected with 
control shRNA(A) and cortactin shRNA(B), selected by puromycin for 4 days, 
then transfected with mito-PAGFP for 18 hours. After transfection, mito-PAGFP-






Subsection 3: Downregulation of cortactin and cofilin induces mitochondrial 
accumulation of Drp1 
Drp1 is the essential regulator of mitochondrial division, during which Drp1 is 
recruited from cytosol to mitochondria to stimulate membrane fission events. To gain 
insight into the mechanism by which cortactin and cofilin regulate mitochondrial 
division, we analyzed the mitochondrial localization of Drp1. HeLa cells transfected 
with control shRNA, cortactin shRNA and cofilin shRNA, were immunostained for 
Drp1 and Tom20 to reveal OMM, followed by structured illumination imaging. We 
found that downregulation of both cortactin and cofilin led to significant increases in 
the amount of mitochondria-associated Drp1 (Fig. 3.13). The degree of colocalization 
of Tom20-labeled mitochondria and Drp1 was quantified and reported as a Mander’s 
correlation coefficient (Rr; Fig. 3.14). The data showed an Rr = 0.44 ± 0.041 in 
control shRNA cells, as compared with an Rr = 0.58 ± 0.06 in cortactin shRNA cells 
and Rr = 0.65 ± 0.034 in cofilin shRNA cells. Because Rr = 1 indicates complete 
colocalization, whereas Rr = 0 indicates random colocalization, Mander’s score 
roughly correlates with percentage of overlap between different fluorescently labeled 
molecules, therefore the data indicated that about 20% more of total Drp1 colocalized 
with mitochondria in cortactin or cofilin shRNA cells than in control shRNA cells 
(Fig. 3.14).  Furthermore, a careful examination of images revealed that 
submitochondrial Drp1 complexes in cortactin and cofilin shRNA cells were larger 






Figure 3.13 Mitochondrial accumulation of Drp1 in control, cortactin and 
cofilin shRNA cells.  HeLa cells were transfected with control shRNA (A), 
cortactin shRNA (B) and cofilin shRNA (C), then immunostained with anti-Drp1 
mAb (green on overlay and detail images) and anti-Tom20 antibody for 
mitochondria (red on overlay and detail images). Images were acquired using 
structured illumination imaging. Maximum projections of seven z-sections 
acquired at 0.25 um intervals starting from the bottom of the cell are shown. Bars: 










We also tested the degree to which cortactin and cofilin could regulate stress-
induced mitochondrial accumulation of F-actin. Control shRNA, cortactin shRNA 
and cofilin shRNA cells were treated with FCCP for 2 min, then fixed and labeled 
with Alexa-Phalloidin and anti-cytochrome c mAb. Quantification analysis of 
Mander’s coefficient revealed that 25.66%  ± 4.22% of cortactin shRNA cells and 
23.00% ± 2.66% in cofilin shRNA cells displaying mitochondrial associated F-actin 
in contrast to 36.67% ± 3.77% of control shRNA cells. FCCP treatment resulted in 
reduced numbers of cells displaying mitochondrial associated F-actin in both 
cortactin and cofilin shRNA cells, compared with control shRNA cells (Fig. 3.15), 
suggesting that mitochondrial associated F-actin polymerization requires the presence 
Figure 3.14 Quantitative analysis of mitochondrial accumulation of Drp1 in 
control, cortactin and cofilin shRNA cells. HeLa cells were transfected with 
control shRNA, cortactin shRNA, and cofilin shRNA, immunostained for Drp1 
and Tom20. Colocalization of Drp1 with mitochondria was analyzed. The values 
represent Mander’s correlation coefficient (Rr) that reveals the degree of 
association of pixels in different channels of the image. Data represent the mean ± 




of cortactin and cofilin. Cortactin and cofilin shRNA reduced protein expression 
level, which is shown in Fig. 3.16. Thus, these data further deepen the understanding 
of the step at which F-actin functions in mitochondrial fission. Given that Drp1 is 
recruited from cytosol to mitochondria upon initiation of mitochondrial fission, 
mitochondrial accumulation of Drp1 in cortactin and cofilin shRNA cells suggested 
that Drp1 recruitment was not controlled by cortactin and cofilin. Considering that 
mitochondrial associated F-actin requires the presence of cortactin and cofilin, we can 
further conclude that mitochondrial F-actin polymerization occurs in parallel with 
mitochondrial recruitment of Drp1. Taking the accumulation of Drp1 on 
mitochondria and abnormal interconnected mitochondrial network in cortactin and 
cofilin knockdown cells together implies that the Drp1-mediated membrane scission 
event is blocked in the absence of cortactin and cofilin, resulting in mitochondrial 
fission defects and excessive Drp1 staying on mitochondria. Thereby, it is very likely 
that mitochondrial F-actin polymerization contributes to Drp1 mediated steps in the 
late stage of mitochondrial fission, such as membrane constriction and/or GTP-





Figure 3.16 Protein expression levels of control, cortactin and cofilin shRNA 
cells. HeLa cells were transfected with control shRNA, cortactin shRNA and 
cofilin shRNA, selected by puromycin and analyzed by Western blot. Blots were 
immunolabeled by anti-cortactin, anti-cofilin and anti-Tom20 antibodies as 
loading control. 
Figure 3.15 Quantitative analysis of mitochondrial assembly of F-actin in 
FCCP-treated control, cortactin and cofilin shRNA cells. Control shRNA, 
cortactin shRNA and cofilin shRNA cells were treated with FCCP for 2 min, fixed 
and then immunostained with Alexa-Phalloidin to detect F-actin and anti-Tom20 
antibody to reveal mitochondria. Data represent mean ± AvDev from a 
representative experiment after triplicate counting of 150 cells/condition. 
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Subsection 4: Mitochondrial association of actin-modifying proteins 
Published reports indicate that cortactin, cofilin, Arp2/3 complexes are 
ubiquitious proteins distributed in the nucleus, cytosol, and membrane compartments 
of the cell, including the cell membrane, ER, and Golgi complex. Implicating a 
critical role for actin-modifying proteins in membrane remodeling events, Arp2/3 
complex, cortactin and cofilin are recruited to clathrin-coated endocytic buds upon 
the initial activation of endocytosis. Using structured illumination imaging, we 
analyzed the spatial relationship between endogenous cortactin, cofilin, or Arp2/3 
complex component Arp3 and mitochondria in wild type and Drp1-/- MEFs. 
Consistent with published data, in wild type MEFs, cortactin (Fig. 3.17), cofilin (Fig. 
3.18) and Arp3 (Fig. 3.19) were enriched within the cytosolic boundaries of the cell 
without showing strong mitochondria colocalization patterns. However a subgroup of 
these proteins colocalized with or was found in close association with mitochondria. 
Although these data do not directly convince that cortactin, cofilin, and Arp2/3 
complex translocate and act at the OMM, we believe that the mitochondrial 
localization of these proteins, in combination with previous data, provides evidence 
suggesting direct mitochondrial roles for cortactin, cofilin and Arp2/3 complex. 
Further supporting this notion, it appears that additional mitochondrial accumulation 
of these proteins was apparent in Drp1-/- MEFs. Notably, in many of Drp1-/- cells a 
mitochondrial pattern of cofilin (Fig. 3.18), Arp3 (Fig. 3.19), and to a lesser degree 
cortactin (Fig. 3.17) was detectable. Quantitative colocalization analysis of Mander’s 
coefficient also revealed that, in contrast to wild type MEFs, Mander’s coefficient 
(Rr) of cortactin, cofilin, and Arp3 colocalization with mitochondrial markers Tom20 
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or cytochorome c was significantly increased in Drp1-/- MEFs (Fig. 3.20). Thus, 
depletion of Drp1 leads to robust mitochondrial accumulation of cortactin, cofilin and 
Arp3. Considering the increased mitochondrial F-actin polymerization in Drp1-/- 
MEFs compared to wild type MEFs shown in chapter 2, these data point to the role of 
increased mitochondrial accumulation of cortactin, cofilin and Arp3 in Drp1-/- MEFs 
acting on OMM in stimulating mitochondrial F-actin assembly and pertinent 
mitochondrial fission events. Given that loss of Drp1 enhanced mitochondrial 
association of actin-modifying proteins, it seems that Drp1 is responsible for the 
disassembly of F-actin nucleating protein complex. Furthermore, FCCP treatment 
induces mitochondrial localization of cofilin and Arp3 to some degree in wild type 
MEFs, implying an FCCP-induced recruitment of cortactin, cofilin and Arp2/3 
complex from cytosol to mitochondria in synchrony with the appearance of 











Figure 3.17 Mitochondrial association of cortactin in wild type and Drp1-/- 
MEFs. Wild type and Drp1-/- MEFs were fixed and immunostained with anti-
cortactin mAb and anti-Tom20 antibody, followed by structured illumination 
imaging. Higher magnifications of areas marked with yellow rectangles are shown 









Figure 3.18 Mitochondrial association of cofilin in wild type and Drp1-/- 
MEFs. Wild type and Drp1-/- MEFs were fixed and immunostained with anti-
cofilin antibody and anti-cytochrome c mAb, followed by structured illumination 
imaging. Higher magnifications of areas marked with yellow rectangles are shown 
in detail images. Bars: 20 µm; (detail) 5 µm. 
 105 
 
Figure 3.19 Mitochondrial association of Arp3 in wild type and Drp1-/- MEFs. 
Wild type and Drp1-/- MEFs were fixed and immunostained with anti-Arp3 
antibody and anti-cytochrome c mAb, followed by structured illumination 
imaging. Higher magnifications of areas marked with yellow rectangles are shown 





Figure 3.20 Quantitative analysis of mitochondrial association of actin-
modifying protein in wild type and Drp1-/- MEFs. Wild type and Drp1-/- MEFs 
were treated with FCCP for 2 min, fixed, immunostained anti-cortactin, anti-
cofilin, anti-Arp3, and anti-Tom20 antibodies. Colocalizations of actin-modifying 
proteins and Tom20 were analyzed. The values represent Mander’s correlation 
coefficient (Rr) that reveal the degree of association of pixels in different channels 
of the image. Data represent the mean ± AvDev of 15 images/condition. Each 
image used for the analyses contained at least two cells. Statistical significance 




Section 4: Discussion 
While Arp2/3 complex and NPFs mediated branched F-actin polymerization 
is the major actin nucleating pathway that contributes to mitochondrial fission, actin 
nucleator formins were reported to promote ER-mediated mitochondrial constriction 
and fission. Linear F-actin nucleator INF2 has been proposed to be an important 
mediator of Drp1-dependent mitochondrial fission and enhance actin presence at ER-
mitochondrial constriction sites (Korobova et al. 2013). Confirming the published 
results, we found that overexpression of ER-localizing INF2 and dominant active 
INF2 mutant INFA149D led to F-actin accumulation on the ER, but not on 
mitochondria. INF2A149D induced abnormal bundling of F-actin associated with 
altered morphology of the ER and mitochondrial fragmentation in INF2A149D-
expressing cells, suggesting that INF2 may mediate ER specific F-actin accumulation, 
rather than mitochondrial positive F-actin polymerization. Overexpression of either 
INF2 or INFA149D induces robust F-actin assembly on the ER and INF2A149D induced 
fragmented mitochondria accumulate along the INF2-positive ER tubules. These data 
further suggest that INF2 induced mitochondrial fragmentation is specifically 
mediated by an ER involved mechanism. It is likely that INF2 nucleated actin 
filaments stay tethered to the ER and form acto-myosin ring with the recruitment of 
myosin II around the mitochondrial fission sites. In our system we were not able to 
detect transient assembly of F-actin on the mitochondrial fission sites and effects of 
INF2 and INF2A149D on mitochondrial assembly of Drp1. Given that the encirclement 
of mitochondria by acto-myosin network pre-constricts the membrane and orients 
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Drp1 recruitment to promote subsequent membrane constriction and scission 
(Korobova et al. 2014a), it is possible that ER-based actin network is not necessary to 
redistribute to the mitochondrial fission sites during membrane constriction mediated 
by Drp1. Alternatively, as membrane constriction and scission is an extremely rapid 
event, the translocation of ER-based actin network to mitochondrial fission sites may 
be very transient and difficult to capture in our system. Furthermore, INF2 
overexpression in HeLa cells did not affect FCCP-induced mitochondrial F-actin 
assembly. Considering that knockdown of actin-modifying proteins Arp2/3 complex, 
cortactin and cofilin resulted in mitochondrial elongation and reduce FCCP-induced 
mitochondrial association of F-actin, we can speculate that INF2- and Arp2/3-
cortactin-cofilin- dependent regulation of mitochondrial fission may occur through 
different mechanisms. 
            In recent years, F-actin assembly has been linked to dynamin superfamily 
proteins, assisting various dynamin-mediated actions in membrane remodeling and 
trafficking (Orth & McNiven 2003; Lanzetti 2007). In our study, we showed that 
downregulation of cortactin and cofilin led to abnormal accumulation of Drp1 on the 
elongated mitochondria, suggesting that Drp1 accumulates on mitochondria as an 
inactive form. It is possible that mitochondrial accumulation of Drp1 observed in 
cortactin or cofilin shRNA cells are caused by a later-than-recruitment Drp1 
regulatory step that was stalled by loss of actin filaments. One possibility is that the 
actin network regulates Drp1 GTPase activity and its oligomerization status on 
mitochondria. In vitro studies have identified a direct dynamin-actin interaction in the 
promotion of dynamin oligomerization through a region on the middle domain of 
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dynamin, implying that actin may bind to Drp1 despite it lacking the C-terminal PRD 
domain to enhance Drp1 oligomerization into higher order structures on 
mitochondria. As dynamin’s GTPase activity is dependent on its oligomerization 
status, the local concentration of short actin filaments generated by shearing or actin-
severing protein-stimulated dynamin’s GTPase activity dependent on dynamin-actin 
interactions (Gu et al. 2010a). Given that downregulation of cofilin induced elongated 
mitochondria and abnormal mitochondrial Drp1 accumulation, it is plausible that 
cofilin may serve as an actin-severing factor to produce short actin filaments at OMM 
that enhance Drp1 GTPase activity and its oligmerization into contractile ring 
structures. Alternatively, actin filaments bundling with myosin can trigger contractile 
force to facilitate membrane constriction and scission. It has been suggested that 
during apical constriction, actin-myosin networks can be organized into contractile 
fibers under plasma membrane, driving the shrinkage of membrane and allowing 
tissue shape changes (Martin et al. 2009). While inhibition of myosin II by 
pharmacological inhibitor or knockdown of myosin II by shRNA resulted in 
abnormal mitochondrial elongation (Korobova et al. 2014a), it is likely that 
mitochondrial F-actin induced by FCCP treatment associates with myosin II to 
provide the membrane tension force to promote mitochondrial membrane constriction 
and help position Drp1 at constriction sites. 
            Understanding the crosstalk between Drp1 and the actin network further 
clarifies the in depth mechanism of mitochondrial fission. In this chapter, we also 
showed that Arp2/3 mediated actin filaments accumulate on mitochondria in the 
absence of functional Drp1. Similarly, cells derived from dynamin1/2 double 
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conditional knockout mice displayed accumulation of actin filaments at the base of 
arrested endocytic clathrin-coated pits (Ferguson & De Camilli 2012). Thus, the 
Arp2/3 dependent F-actin nucleation and polymerization on mitochondria appears to 
be Drp1-independent. As the disassembly of F-actin requires the presence of 
functional Drp1 GTPase activity, it is plausible that the depolymerization of 
mitochondrial actin is initiated by Drp1 mediated GTP hydrolysis. Given the 
abnormal accumulation of Drp1 on mitochondria in cortactin and cofilin knockdown 
cells, it suggests that both F-actin polymerization on the OMM and mitochondrial 
assembly of Drp1 are required to complete Drp1-dependent mitochondrial fission. In 
addition, dynamin was linked to actin filaments by either direct interaction or actin 
binding proteins such as profilin, Nck and cortactin (Gu et al. 2010b). The SH3 
domain of cortactin is reported to interact with the PRD region of dynamin, forming 
ring-like structures at membrane remodeling sites in various cellular compartments 
(Orth & McNiven 2003). However, given the fact that Drp1 lacks a PRD domain on 
the C-terminus, it is possible that cortactin and Drp1 coordinate to regulate actin 




Chapter 4: Regulation of mitochondrial fission complexes and 
mitochondrial division by deubiquitinase Usp30 
 
Section 1: Introduction 
            More than 95 deubiquitinases (DUBs) are encoded by the human genome. 
DUBs can be further classified into two main categories: cysteine proteases and 
metalloproteases (Nijman et al. 2005). Cysteine protease Usp30 is the only known 
mitochondrial associated DUB. Usp30 is anchored to the OMM through a N-terminal 
transmembrane domain, that is followed by a catalytic domain mediating the DUB 
activity (Nakamura & Hirose 2008). It has been shown that Usp30 can mediate 
removal of K-48- and K-63- linked polyubiquitinatin chains. It has been also shown 
that Usp30 regulates mitochondrial network organization, likely through modifying 
non-degradative ubiquitination of mitochondrial morphological factors. While 
overexpression of Usp30 did not affect mitochondrial morphology, knockdown of 
Usp30 by shRNA resulted in mitochondrial elongation in HeLa cells (Nakamura & 
Hirose 2008). In addition, Usp30 was able to reverse diterpenoid derivative 15-
oxospiramilactone (S3) - induced mitochondrial fragmentation to restore the 
mitochondrial network in either Mfn1 or Mfn2 knockout cells. The inhibition of 
Usp30 by S3 led to an increase of non-degradative ubiquitination of Mfn1/2, which 
enhanced Mfn1 and Mfn2 activity and promoted mitochondrial fusion (Yue et al. 
2014). These studies also suggested that Usp30 physically interacted with Mfn1/2 and 
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decreased non-canonical ubiquitination of Mfn1/2 on cysteine residue, resulting in 
impaired mitochondrial fusion activity. 
            Apart from regulating mitochondrial morphology, recent studies showed that 
Usp30 opposes PINK1/Parkin-mediated mitochondria-specific autophagy 
(mitophagy) by antagonizing E3 Ub ligase Parkin mediated ubiquitination of various 
OMM proteins. When overexpressed, Usp30 removed Ub attached to the OMM 
proteins modified by Parkin on damaged mitochondria and blocked Parkin-driven 
mitophagy, whereas loss of Usp30 activity rescued defective mitophagy caused by 
pathogenic mutations in Parkin and improved mitochondrial integrity in Parkin- or 
PINK1- deficient flies (Bingol et al. 2014). These data suggest that Usp30 and Parkin 
form a paired system that modulates mitophagy. Global ubiquitination profiling 
identified multiple mitochondrial substrates oppositely regulated by Parkin and 
Usp30, including Tom20, MIRO1, VDAC and FKBP8 (Cunningham et al. 2015). 
Further confirming a Usp30-dependent mechanism of mitochondrial protein 
deubiquitination, mass spectrometry and peptide quantification showed that Usp30 
preferentially removes K-6 and K-11 Ub chains from intact mitochondria upon CCCP 
treatment (inducer of mitophagy), whereas mitochondrial damage stimulates parkin to 
assemble K-6-, K-11- and K-63- linked polyubiquitin chains on mitochondria 
(Cunningham et al. 2015).  
            It also appears that Usp30-dependent Ub dynamics at the OMM contributes to 
apoptotic cell death (Liang et al. 2015). Usp30 deletion enhanced CCCP-induced cell 
death in Parkin overexpressing cells, suggesting that the presence of Usp30 delays 
CCCP-induced cell death caused by excessive Parkin activation. Moreover, Usp30 
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deletion by siRNA sensitized cells to BH3-mimetics ABT-737 and ABT-263 
independent of Parkin overexpression, suggesting that Usp30 counteracts Bax/Bak-
dependent apoptosis. 
            In this chapter, I report that Usp30 also controls Drp1-mediated mitochondrial 
division. I found that loss of Usp30 DUB activity resulted in elongated mitochondrial 
network, stabilization of Drp1-containing mitochondrial fission complexes and actin 
filaments on mitochondrial surface, suggesting a novel role of Usp30 in regulating 
mitochondrial fission. 
Section 2: Materials and Methods 
Subsection 1: Cell culture 
HeLa cells were cultured in DMEM medium supplemented with 10% heat-
inactivated fetal bovine serum, 2 mM Glutamax, 1 mM sodium pyruvate, 1 mM non-
essential amino acids, 100 U/ml penicillin in 5% CO2 at 37°C. Wild type and Usp30-/- 
HCT116 cells generated by CRISPR/Cas9 technology were cultured in McCoy’s 5A 
medium supplemented with 10% heat-inactivated fetal bovine serum, 2 mM 
Glutamax, 1 mM sodium pyruvate, 1 mM non-essential amino acids, 100 U/ml 
penicillin in 5% CO2 at 37°C. 
Subsection 2: General experimental methods 
Cell transfection, immunofluorescence, image acquisition, live cell imaging, 
and Western blot were performed as described in Chapter 2 (Section 2 Materials and 
Methods) and Chapter 3 (Section 2 Materials and Methods). 
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Subsection 3: DNA expression constructs 
FLAG-Usp30WT, FLAG-Usp30CS and FLAG-Usp30ΔTM mammalian 
expression constructs were described previously (Nakamura & Hirose 2008) and 
kindly provided by Dr. Nakamura (Tokyo Institute of Technology, Japan). YFP-Drp1 
was described before (Karbowski et al. 2007). mRuby-Lifeact construct was also 
already described before (Riedl et al. 2008) and kindly provided by Dr. T. Blanpied 
(University of Maryland Baltimore, USA). 
Subsection 4: Antibodies 
The primary antibodies used for immunofluorescence studies were anti-
Tom20 polyclonal antibody (1:2000; Santa Cruz), anti-cytochrome c mAb (1:500; 
BD Biosciences), anti-Usp30 (1:500; Sigma-Aldrich) and anti-FLAG monoclonal and 
polyclonal antibodies were from Sigma-Aldrich (St. Louis, MO). The primary 
antibodies used for Western blot were anti-Usp30 polyclonal antibody (1:1000; 
Sigma-Aldrich), anti-Drp1 monoclonal antibody (1:1000; BD Biosciences), anti-
Tom20 polyclonal antibody (1:5000; Santa Cruz) and anti-FLAG tag antibodies 
(1:5000; Sigma-Aldrich). 
Subsection 5: Fluorescence recovery after photobleaching (FRAP) analysis 
FRAP of YFP-Drp1 was performed as described earlier (Karbowski et al. 
2007). Briefly, cells were examined through a 40x plan-Neofluar oil immersion 
objective (NA=1.3) on an inverted microscope (AxioObserver Z1; Zeiss 
MicroImaging) with a laser scanning confocal microscope (LSM 510) controlled by 
Zeiss Efficient Navigation (Zen 2009) software. YFP-Drp1 was excited using a 514 
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nm argon laser, while fluorescent emission was isolated using a 535-590 nm band-
pass filter and collected on a photomultiplier tube. Regions of interest (~ 5 µm2) were 
bleached by repetitive scanning (50 iterations) with the 514 nm laser (25 mW) at 
maximal emission over ~5s. Fluorescent recovery was monitored at an acquisition 
rate of 0.63 frame/s.  Focus stability during time-lapse recordings was maintained 
using the definite focus module, an add-on for the Observer Z1. All FRAP 
experiments were conducted at room temperature. Image analyses were performed 
using either Efficient Navigation (Zen 2009) software or AxioVision 4 software, both 
supplied by Zeiss MicroImaging.  
Subsection 6: Super-resolution direct stochastic optical reconstruction microscopy 
(dSTORM) 
The single-molecule-based super-resolution dSTORM determines the precise 
position of individual fluorophores that are further apart than the minimal distance 
resolved by the microscope by evaluating their diffraction patterns in the imaging 
plane, thus, are heavily dependent on the number of detected photons (van de Linde et 
al. 2011).  A super-resolution fluorescence image is finally reconstructed by summing 
up all localizations. The temporal seperation of fluorophore emission is achieved by 
the photoactivated or reversibly photoswitched fluorescent proteins and organic 
fluorophores between OFF state earned by reducting thiol compound that efficiently 
quenches the fluorophore’s triplet state and generates a stable non-fluorescent 
reduced state (dark) and ON state by spontaneously recovering of fluorophore in 
aqueous solvents (Heilemann et al. 2009). 
 116 
 
dSTORM imaging was accomplished using the ELYRA PS.1 super-resolution 
platform (Zeiss MicroImaging). (dSTORM), a recently developed super-resolution 
microscopy technology with typical resolutions of 30-50nm, up to 10 times higher 
than the resolution of confocal microscopy. Following immunocytochemistry 
staining, cells were imaged through a 100x alpha Plan-Apochromat oil immersion 
objective (NA=1.46) on an inverted microscope (AxoObserver Z1). The combination 
of a strong reducing buffer (dSTORM buffer: 44.4 mM Tris, 9.2 mM NaCl, 8.8% 
glucose, 0.56 mg/ml Glucose Oxidase, 0.034 mg/ml Catalase, and 100 mM MEA), 
and a powerful 100mW solid-state 642 nm laser in the total internal fluorescence 
(TIRF) configuration was used to cause the fluorophore [Alexa 647; in conjugation 
with anti-Drp1 monoclonal antibody (BD Bioscences) used to detect endogenous 
Drp1 protein] to continually switch from bright to dark states. Fluorescent emission 
was acquired by an Andor iXon 897 camera after passing through a 655 nm long-pass 
filter. Acquisition control and image analysis was completed using Zeiss Efficient 
Navigation (Zen 2010D) software, which allowed for single molecule localization 
and drift correction.  
Subsection 7: Subcellular fractionation 
Cells were harvested, and total cell protein lysates and subcellular fractions 
were prepared as previously described (Karbowski et al. 2007). Cells were harvested 
18 hours after transfection and then suspended in swelling buffer (10 mM HEPEs, 10 
mM NaCl, 1.5 mM MgCl2). Cells were disrupted by 15 passages through a 25-gauge 
needle (with 1-ml syringe). The heavy membrane fraction (HM) was obtained by 
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centrifugation at 6,000 g for 10 min. Protein lysates were analysed by 4-20% SDS-
PAGE followed by Western blot. 
Subsection 8: Blue Native PAGE, crosslinking and immunoprecipitation 
Blue Native PAGE (BN-PAGE) was performed with Native PAGE 3-12% 
Bis-Tris gel system, using cell lysates obtained by incubation with 1% DDM (n-
dodecyl β-D-maltoside; Invitrogen) in BN-PAGE sample buffer for 30 min, following 
the manufacturer’s recommendations (Invitrogen). Immunoprecipitation (IP) was 
performed as previously described (Benard et al. 2010). Cells were harvested and 
lysed using IP lysis buffer containing: 25 mM Tris (pH7.4); 0.15 M NaCl; 1 mM 
EDTA; 1% NP-40; 5 mM N-Ethylmaleimide and protease inhibitors cocktail 
(Roche), followed by immunoprecipitation using anti-FLAG monoclonal antibody 
(Sigma-Aldrich). Reversible cross-linking was performed with Dithiobis 
(Succinimidyl propionate) (DSP; Thermo Scientific). Briefly, cells were washed with 
PBS, followed by incubation in with 1 mM DSP in PBS containing Ca2+ and Mg2+, 
for 2 hours on ice. The reaction was stopped by addition of 20mM Tris pH 7.4, and 
then crosslinked cell were collected and processed for IP. Irreversible crosslinking 
was performed with bismaleimidohexane (BMH; Life technologies). Cells was 
harvested, washed with PBS, and incubated with in 1 mM BMH in PBS for 30 min on 
ice.  
Subsection 9: Generation of Usp30 knockout cells by CRISPR/Cas9 technology 
To generate knockout cells in the Karbowski lab, we adopted a gRNA 
synthesis protocol generated by the Church lab (Mali et al. 2013), and a protocol 
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established by Orkin for efficient deletion of desired genomic regions in mammalian 
cells. Usp30 (Gene ID 84749) is encoded by 4145 nucleotides assembled on 
chromosome 12 (GRCh38.p2), NC_000012.12 (109023089-109088026). The Usp30 
gene consists of 14 exons, and the coding sequence of Usp30 ranges from 110-1663 
spreading between exon 1 and exon 14. The DUB domain catalytic site Cys77 is 
localized on exon 3 (303-485) (109,057,926-109,058,108). In order to deplete Usp30, 
we designed two gRNA constructs that target both sides of the exon 3 with a 23 bp 
genomic sites of the form 5’-N20NGG-3’, utilizing the online design tool DNA2.0 
CRISPR gRNA design tool (https://www.dna20.com/eCommerce/cas9/input). gRNA 
1# targets sequence ranging from 109,057,907 to 109,057,929 on minus (-) strand, 
which localizes upstream of exon 3 with three nucleotides overlapping with 5’ of 
exon 3. The Cas9 cleavage site is at 109,057,912-109,057,913 (Fig. 4.2). gRNA 2# 
targets sequence ranging from 109,058,060 to 109,058,083 on minus strand, which 
completely localized inside exon 3 close to the 3’-site. In this case, the Cas9 cleavage 
site was at 109,058,065-109,058,066 (Fig.4.2). The double-guided Cas9 cleavage led 
to a double DSB with NHEJ repair, which results in a 100 segments deletion of exon 
3. Following gRNA synthesis protocol, we incorporated 19 bp (green region in 
Fig.4.4 and 4.5) of selected target sequence and its reverse complements into two 60 
mer oligonucleotides as shown as step 2 in Fig.4.1 (reverse complements shown as 
red regions in Fig.4.4 and 4.5). After synthesizing these oligonucleotides, we 
annealed and extended these two oligonucleotides based on the overlapping region to 
yield a 100 bp double-stranded DNA fragments by using DNA polymerase. Then, we 
digested the gRNA cloning vector using AfIII and incorporated the 100 bp DNA 
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fragments with gRNA cloning vector using Gibson assembly, based on the 20-40 
overlapping base-pairs between vector and DNA fragments, to obtain the desired 
gRNA constructs. 
Following a protocol established to generate gene deletion in mammalian cell 
lines (Bauer et al. 2014), to introduce gRNA into cells we co-transfected gRNA1#, 
gRNA2#, Cas9 and YFP-tag into parental HCT116 cells by Lipofectamine 2000. 
YFP-tag was used as a marker to label transfected cells. After 18 hours, the bulk cells 
were collected, and prepared in a FACS tube. Then the heterogeneous cell mixture 
was sorted by YFP-positive fluorescence using Fluorescence-activated cell sorting 
(FACS), then plated one cell at a time to a 96-well plate in order to isolate single cell 
colonies. Cells in 96-well plates were incubated at 37 degrees for 1-2 weeks. After 
that, we reseeded the single cell colony that can be visualized under a microscope into 
cell culture plates for future screening (see Fig. 4.1 for general process).  
To screen for the CRISPR/Cas9 clones, we validated the Usp30 deletion by 
evaluating both genomic DNA sequence and protein expression levels. To verify the 
DNA depletion, we design one set of internal primers and one set of external primers 
to validate the monoallelic or biallelic deletion clones (Fig. 4.3). The external primers 
are 5’-CATGTAGGGGAGAATGAGGA-3’ and 5’-
GTATCTATTGGGCTCTTGGTG-3’, which are localized at about ~300bp upstream 
(109,057,590-109,056,609) and down stream of Usp30 exon 3 cleavage sites, while 
the internal primers are 5’-GTTAGGATAAATACTGGTGTGAG-3’ and 5’-
CTGTTCTCTTGTTCCCCCTG-3’, covering the Cas9 cleavage sites sequence at 
both ends of exon 3 (Fig.4.3). We analyzed the genomic DNA by amplifying them 
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with these two sets of primers independently. We would be able to categorized the 
PCR results in three scenarios: (1) non-deletion: the presence of both ~800 bp band 
(external primers) and ~100 bp band (internal primers); (2) monoallelic deletion: the 
presence of ~800 bp band (external primers) and the absence of ~100 bp band 
(internal primers); (3) biallelic deletion: the presence of ~700 bp (external primers) 
and the absence of ~100 bp band (internal primers). The genome DNA results 
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Section 3: Results 
Subsection 1: Expression of DUB activity-deficient Usp30CS promotes mitochondrial 
elongation associated with mitochondrial accumulation of Drp1  
Usp30 is a 517 amino acid protein, featuring an N-terminal transmembrane 
domain (residues 35-54), followed by a DUB catalytic domain (residues 69-499) 
(Figure 4.6) (Nakamura & Hirose 2008). First, we analyzed the subcellular 
localization of endogenous Usp30. HeLa cells were immunostained for Usp30 and 
cytochrome c, to reveal mitochondria, followed by structured illumination imaging. 
Immunofluorescence analysis revealed clear mitochondrial localization of 
endogenous Usp30 (Fig. 4.7). This result was also confirmed by cell fractionation 
analysis. Endogenous Usp30 was concentrated in mitochondria-enriched heavy 
membrane (HM) fractions, but not light membrane (LM) and cytosolic fractions (Fig. 
4.8), in a similar manner to the OMM marker Tom20, further confirming that Usp30 
is a mitochondrial protein.  
 
A dominant negative mutant was generated by the mutation of the conserved 
cysteine residue (Cys77 to Ser; Usp30CS) that was shown to abolish Usp30 DUB 
catalytic activity (Nakamura & Hirose 2008). To test the effect of Usp30CS on 
Figure 4.6 Usp30 domain organizations. Usp30 contains 517 amino acids 
featuring an N-terminal transmembrane domain and a central DUB domain.  
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mitochondrial network organization, HeLa cells were transfected with FLAG-
Usp30WT and FLAG-Usp30CS, fixed and immunostained with anti-FLAG antibody to 
detect exogenous Usp30 and anti-cytochrome c mAb, to reveal mitochondria 
followed by structured illumination imaging. While low expression levels of FLAG-
tagged Usp30WT or FLAG-Usp30CS did not affect mitochondrial structure, as 
compared to untransfected control cells, higher expression levels of FLAG-Usp30WT 
or FLAG-Usp30CS resulted in dramatic differences in mitochondrial network 
organizations. While overexpression of FLAG-Usp30WT induced mild fragmentation 
of mitochondrial tubules, expression of FLAG-Usp30CS led to an extensive 
Figure 4.7 Subcellular localization of endogenous Usp30 in HeLa cells. HeLa 
cells were fixed and immunostained with anti-Usp30 antibody to detect 
endogenous Usp30 and anti-cytochrome c mAb to reveal mitochondria, followed 
by structured illumination imaging. Higher magnifications of areas marked with 
white rectangles are shown in detail images. 
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mitochondrial tubulation (Fig. 4.9). Interestingly, mitochondrial changes observed in 
cells expressing higher levels of FLAG-Usp30CS, formation of thin elongated 
mitochondrial tubules in particular, were highly reminiscent of the mitochondrial 
alterations induced by overexpression of recently identified mitochondrial fission 
factors MiD49 and MiD51. Given that overexpression of MiD49/51 led to abnormal 
accumulation of mitochondrial fission protein Drp1 on mitochondrial tubules, 
therefore suggesting that MiD49/51 may serve as mitochondrial receptor of Drp1, we 
also tested the effects of FLAG-Usp30WT and FLAG-Usp30CS on subcellular 





Figure 4.8 Subcellular localization of Usp30. Total cell lysate (TCL), heavy 
membrane fraction (HM), light membrane fraction (LM), and cytosol fraction 
were isolated from HeLa cells and analyzed by Western blot. Blots were 












Figure 4.9 The effect in mitochondrial network organization of 
overexpression of Usp30WT and Usp30CS. HeLa cells were transfected with 
FLAG-tagged Usp30WT and FLAG-Usp30CS, immunostained with anti-FLAG 
antibody (green on the overlay image) and anti-cytochrome c mAb (red on the 




To achieve this, HeLa cells transfected with FLAG-Usp30WT and FLAG-
Usp30CS, were immunostained with anti-FLAG antibody to label exogenous Usp30 
and anti-Drp1 antibodies to detect endogenous Drp1, followed by structured 
illumination imaging. Expression of FLAG-Usp30CS led to a dramatic redistribution 
of endogenous Drp1 from the cytosol to the mitochondria in a similar manner to 
Figure 4.10 Mitochondrial associated Drp1 accumulation in Usp30WT and 
Usp30CS-expressing cells. HeLa cells were transfected with FLAG-Usp30WT and 
FLAG-Usp30CS, fixed and immunostained with anti-FLAG to reveal exogenous 




MiD49/51 overexpression, while overexpression of FLAG-Usp30WT did not alter 
subcellular localization of Drp1 (Fig. 4.10). The degree of mitochondria-associated 
Drp1 increase appeared to positively correlate with the expression level of Usp30CS. 
These results were further confirmed by cell fractionation. Subcellular fractions 
isolated from untransfected HeLa cells and cells transfected with FLAG-Usp30WT, 
FLAG-Usp30CS, or FLAG-Usp30ΔTM (transmembrane domain-deficient Usp30 
mutant) were analyzed by Western blot. The data showed that Drp1 accumulated in 
the mitochondria-enriched HM fractions in Usp30CS-expressing cells, but not in 
Usp30WT or Usp30ΔTM-expressing cells (Fig.4.11). Thus, Usp30CS appears to induce 
mitochondrial elongation associated with mitochondrial accumulation of Drp1, 
suggesting that Usp30 may control mitochondrial division via regulating the 
trafficking of Drp1 between the mitochondria and the cytosol. 
 
Figure 4.11 Subcellular fractionation of Usp30WT-, Usp30CS- and Usp30ΔTM- 
expressing cells. HeLa cells transfected with FLAG-Usp30WT, FLAG-Usp30CS 
and FLAG-Usp30ΔTM, were fractionated and analyzed by Western blot. Blots were 
immunostained with anti-Drp1 mAb, anti-FLAG antibody to detect exogenous 
Usp30, and anti-Tom20 antibody as loading control. 
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Subsection 2: Usp30 deletion results in mitochondrial elongation 
To verify the role of Usp30 in the control of mitochondrial division, using 
CRISPR/Cas9 technology, we generated Usp30 knockout HCT116 cells. The 
successful Usp30 knockouts were verified by Western blot (Fig 4.12). We 
investigated the mitochondrial morphology in wild type and Usp30 knockout (Usp30-
/-) HCT116 cells. Parental cells and 3 different clones of Usp30-/- HCT116 cells were 
fixed and immunostained with anti-cytochrome c mAb to reveal mitochondrial 
network morphology. The data showed that Usp30-/- cells exhibited extensively 
elongated and interconnected mitochondrial tubules (Fig. 4.13), as compared to 
parental HCT116 cells. 
 
 
Figure 4.12 Usp30 expression in parental and Usp30-/- HCT116 cells. Total cell 
lysate from Wild type and three clones of Usp30-/- HCT116 cells were analyzed by 
Western blot. Blots were immunolabeled with anti-Usp30 antibody to detect 




Figure 4.13 Mitochondrial morphology in Usp30-/- HCT116 cells. Wild type 
and 3 clones of Usp30-/- HCT116 cells were fixed and immunostained with anti-
cytochrome c mAb. The mitochondrial-enriched z-sections corresponding to the 
vertical part of the cells were stacked. Higher magnifications of areas marked with 
rectangles are shown in detail images. 
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Subsection 3: Expression of Usp30CS induces high molecular weight Drp1 complex 
formation 
            Given that overexpression of Usp30CS led to mitochondrial elongation 
accompanied by the mitochondrial accumulation of Drp1, it is possible that Usp30 
controls mitochondrial fission steps downstream of mitochondrial Drp1 recruitment.  
Under this scenario, Drp1 would accumulate and oligomerize on the OMM but would 
not be able to complete mitochondrial membrane scission. To test this hypothesis, we 
first examined whether Usp30 interacted with Drp1 on the mitochondria. 
Untransfected cells and cells transfected with FLAG-Usp30WT and FLAG-Usp30CS 
were lysed, and ectopically expressed Usp30 was immunoprecipitated with anti-
FLAG antibody, followed by Western blot analysis. In addition, to increase the 
chance to reveal the physical interaction between these proteins, a reversible 
membrane permeable chemical crosslinker Dithiobis(succinimidyl propionate) (DSP) 
was applied to the cell culture dishes prior to cell lysis and immunoprecipitation. The 
data showed that while Drp1 coimmunoprecipitated with Usp30CS in both DSP-
treated and untreated cells, a detectable coimmunoprecipitation of Drp1 with wild 
type Usp30 was observed only in DSP-treated cells. Furthermore, application of DSP 
increased the amount of Drp1 coimmunoprecipitating with Usp30CS, as compared to 
non-crosslinked samples. These data support the possibility that inactivation of the 
Usp30 DUB domain led to stabilization of normally transient/weak protein complexes 
containing Usp30 and Drp1 (Fig. 4.14).  
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Upon recruitment from the cytosol to the mitochondria, Drp1 oligomerizes, 
and these oligomers are believed to mediate mitochondrial membrane scission. To 
test whether Usp30 is involved in the regulation of mitochondrial Drp1 
oligomerization, we applied Blue Native polyacrylamide gel electrophoresis (BN-
PAGE). Consistent with published data, in control cells Drp1 was detected as a ~240 
kD complex. While the same Drp1 pattern was also detected in cells expressing 
Usp30WT, expression of Usp30CS led to formation of higher molecular weight Drp1 
complexes, suggesting that Usp30CS either promotes the formation of Drp1 oligomers, 
or inhibits disassembly of these structures (Fig. 4.15).  
 
 
Figure 4.14 Immunoprecipitation of ectopically expressed Usp30 in HeLa 
cells. Untransfected cells and cells transfected with FLAG-Usp30WT and FLAG-
Usp30CS were (A) directly immunoprecipitated by anti-FLAG antibody, (B) 
incubated with DSP prior to lysis, then immunoprecipitated by anti-FLAG 
antibody, and analyzed by Western blot. Blots were immunostained by anti-




Furthermore, non-reversible crosslinker bismaleimidohexane (BMH) was also 
employed to analyze the oligomeric status of Drp1. Total cell lysates and 
mitochondria-enriched HM fractions isolated from HeLa cells transfected with either 
Usp30 or Usp30CS were crosslinked by BMH and then analyzed by Western blot. 
Confirming BN-PAGE analysis, high molecular weight Drp1 complexes, were 
detected in crosslinked TCL isolated from the cells expressing Usp30CS. The 
accumulation of Drp1 oligomers in Usp30CS-expressing cells was even more apparent 
in HM fractions, suggesting that Usp30CS expression specifically affected 
oligomerization of the mitochondria-associated subset of Drp1 (Fig. 4.16).  
Figure 4.15 Formation of high molecular weight complex of Drp1 in Usp30WT- 
and Usp30CS- expressing cells. HeLa cells were transfected with Usp30WT and 
Usp30CS, and analyzed by BN-PAGE followed by Western blot. Blots were 
immunostained by anti-Mff, anti-Mfn1 and anti-Drp1 antibodies.         
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            Given that oligomeric status of Drp1 is controlled by Usp30 activity, we 
further tested the assembly status of Drp1 on the mitochondria by taking advantage of 
dSTORM. Cells transfected with YFP-vector (control), FLAG-Usp30WT and FLAG-
Usp30CS were processed for immunofluorescence, using anti-FLAG antibody 
followed by Alexa-488 secondary antibody (to detect cells expressing Usp30), and 
anti-Drp1 antibody followed by Alexa-647 secondary antibody. FLAG-Usp30WT- and 
FLAG-Usp30CS- expressing cells were identifed by green fluorescence signal and 
followed by STORM anlysis of Alexa-647 fluorescence signal in FLAG tag-postitive 
cells. While there was no apparent difference in the size and distribution of Drp1 in 
control and FLAG-Usp30WT-expressing cells, confirming immunofluorescence and 
biochemical studies, a significant increase in the size of Drp1 clusters was apparent in 
Figure 4.16 BMH crosslinking in total cell lysate and mitochondrial 
fractionation of Usp30WT- and Usp30CS- expressing cells. HeLa cells were 
transfected with Usp30WT and Usp30CS, fractionated, crosslinked by BMH, and 
then analyzed by Western blot. Blots were immunostained by anti-Mfn1, anti-
Drp1 and anti-Fis1 antibodies.         
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FLAG-Usp30CS-expressing cells (Fig. 4.17). Furthermore, Drp1 clusters in FLAG-
Usp30CS-expressing cells formed organized assemblies, reminiscent of the Drp1 
spirals predicted to be formed before completion of the mitochondrial fission process.  
The data showing that expression of Usp30CS has a strong impact on the 
subcellular localization of Drp1 suggest that Usp30 is involved in the regulation of 
Drp1 and mitochondrial fission complexes. Drp1 and its yeast homologue Dnm1 
cycle between the cytosol and the mitochodnria. It is possible that the abnormal 
accumulation of Drp1 on the OMM in the response to the expression of Usp30CS is 
Figure 4.17 dSTORM microscopy of Drp1 organization in Usp30WT- and 
Usp30CS- expressing cells. HeLa cells were transfected with YFP-vector, 
Usp30WT and Usp30CS, then immunostained with anti-FLAG antibody followed by 
Alexa-488 antibody, and anti-Drp1 mAb followed by Alexa-647 antibody. 
Usp30WT- and Usp30CS- expressing cells were identified by 488 fluorescent 
signals, and then analyzed by STORM microscopy. Higher magnifications are 
shown in detail images. 
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caused by changes in the subcellular dynamics of Drp1. However, it is also likely that 
this is caused by anomalous transitions between distinct steps of Drp1-dependent 
mitochondrial fission, after Drp1 is recruited to the mitochondria in the Usp30-
independent manner. The following experiments tested these possibilities. First, the 
mobility of YFP-Drp1 in cells cotransfected with Usp30WT, Usp30CS and YFP-Drp1 
(Usp30/Drp1 ratio 6:1) or in YFP-Drp1 only transfected cells was analyzed by 
fluorescence recovery after photobleaching (FRAP) assay. Like endogenous Drp1, 
YFP-Drp1 accumulated on the mitochondria in Usp30CS-expressing cells. To measure 
FRAP, regions of interests (ROIs) selected within YFP-Drp1-expressing cells were 
photobleached by irradiation with a high-power laser and subsequent fluorescence 
recovery within the ROIs was monitored over ~180 seconds. As shown in Fig.4.18, a 
distinct decline in the mobility of YFP-Drp1 in cells coexpressing Usp30CS   and YFP-
Drp1 was evident, as compared to cells expressing YFP-Drp1 only, or Drp1 and wild 
type Usp30.            
In sum, the data described above demonstrate that expression of catalytically 
inactive Usp30 mutant leads to abnormal stabilization of mitochondrial associated 
Drp1. Since Drp1 fission complexes in these cells are larger than in control or 
Usp30WT-expressing cells, it is possible that Usp30 participate in late stages of 





Subsection 4: Mitochondrial and Drp1 remodeling upon forced mitochondrial 
division 
It is well established that mitochondrial uncoupler FCCP or CCCP can induce 
Drp1-dependent mitochondrial fission. These compounds are commonly used to 
determine whether mitochondrial phenotypes, most often elongation of mitochondrial 
tubules, are induced by the activity of Drp1. FCCP/CCCP-induced mitochondrial 
fragmentation was inhibited in Drp1 knockout cells, or cells with a reduced level of 
mitochondrial Drp1 receptor Mff or MiD49/51, suggesting that FCCP/CCCP induced 
mitochondrial fragmentation is Drp1-dependent. Furthermore, the data I discussed in 
Chapter 3 also support the possibility that actin-modifying proteins are required for 
Figure 4.18 The motility of YFP-Drp1 in Usp30WT- and Usp30CS- expressing 
cells analyzed by FRAP.  HeLa cells were cotransfected with YFP-Drp1, YFP-
Drp1 and Usp30WT, or YFP-Drp1 and Usp30CS, analyzed by FRAP. 
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Drp1-dependent FCCP-induced mitochondrial fission. By using FCCP as a trigger for 
mitochondrial fission, combined with time-lapse microscopy, we tested the 
submitochondrial remodeling of Drp1 in control, Usp30WT- and Usp30CS- expressing 
cells. Cells were cotransfected with Usp30WT or Usp30CS and YFP-Drp1 
(Usp30/Drp1 ratio 6:1) or transfected with only YFP-Drp1, treated with FCCP, 
followed by time-lapse structured illumination imaging. While only minor changes in 
the subcellular distribution of YFP-Drp1 in control and Usp30-expressing cells were 
detected, FCCP induced a gradual tubulation of the Drp1-containing structure in 
Usp30CS-expressing cells (Fig.4.19). These thin and elongated structures resembled 
those formed by the mitochondria in cells expressing higher levels of Usp30CS. In 
addition, treatment with FCCP also induced mitochondrial tubulation in Usp30CS-
expressing cells, confirming the mitochondrial localization of tubular Drp1 structures. 
Given that Drp1 oligomerizes on the OMM to mediate mitochondrial fission, we also 
utilized Blue Native PAGE (BN-PAGE) to determine the oligomeric status of Drp1 
upon FCCP treatment. Control, Usp30WT- and Usp30CS-expressing cells were treated 
with FCCP, harvested and analyzed by BN-PAGE. The data showed that FCCP 
treatment led to a further increase in formation of high molecular weight Drp1 
complexes in Usp30CS-expressing cells, but did not affect Drp1 complexes in control 
and Usp30WT-expressing cells (Fig. 4.20). Thus, unlike in any known situations 
FCCP induced a dramatic tubulation of the mitochondria, suggesting that although 
Usp30 appears to regulate Drp1-mediated mitochondrial scission, not an initial 
mitochondrial assembly of Drp1, but rather steps in mitochondrial fission occurring 
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Figure 4.19 Drp1 tubulation induced by FCCP in Usp30CS-expressing 
cells. HeLa cells were cotransfected Usp30CS and YFP-Drp1, treated with 
FCCP, and followed by time-lapse structured illumination microscopy.  
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Given that mitochondrial Drp1 recruitment and mitochondrial F-actin 
assembly are two parallel pathways that contributes to Drp1 dependent mitochondrial 
fission (see Chapter 2 and 3), I further investigated the mitochondrial network 
organization and mitochondrial F-actin polymerization in control, Usp30WT- and 
Usp30CS-expressing cells upon FCCP treatment. Cells were cotransfected with 
Usp30WT or Usp30CS together with YFP-Drp1 and mRuby-Lifeact (ratio 5:1:1), 
treated with FCCP, and then analyzed by time-lapse structured illumination 
microscopy. Given that Drp1 is recruited to the OMM when treated with FCCP, it is 
believed that YFP-Drp1 is able to reveal mitochondrial structure upon FCCP 
Figure 4.20 Oligomeric status of Drp1 in FCCP-treated control, Usp30WT- 
and Usp30CS- expressing cells. HeLa cells were transfected with YFP-tag, 
Usp30WT and Usp30CS, then treated with FCCP and then analyzed by BN-PAGE 
and Western blot. The blot was then immunolabeled with anti-Drp1 mAb. 
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treatment. The data showed that upon FCCP treatment, a tubular mitochondrial 
network emerged in Usp30CS-expressing cells. Interestingly, the formation of thin and 
elongated mRuby-Lifeact-positive structures was also observed in Usp30CS-
expressing cells (Fig. 4.21 and Fig. 4.22), but not in control or Usp30WT-expressing 
cells. These F-actin positive tubular structures colocalized with YFP-Drp1, indicating 
that, similar to Drp1 forming a mitochondrial tubular structure, F-actin also 
assembled and accumulated on mitochondria in Usp30CS-expressing cells upon FCCP 
treatment. It has been shown that in cells overexpressing MiD49/51, the thin and 
extended mitochondrial tubules, resembling those in Usp30CS-expressing cells, also 
colocalized with F-actin. Furthermore, upon treatment with actin polymerization 
inhibitor cytochalasin D, these structures retracted. My data also showed that 
pretreatment with actin polymerization inhibitor LatB, completely inhibited both F-
actin polymerization and mitochondrial tubulation, suggesting the possibility that F-
actin polymerization may contribute to the formation of mitochondrial tubules in 
Usp30CS-expressing cells. The data also showed that Usp30CS-induced remodeling of 
mitochondrial Drp1 occurred in a similar timeframe as formation of newly assembled 
F-actin fibers (Fig. 4.21 and Fig. 4.22), providing additional evidence supporting the 
possibility that Drp1 together with mitochondrial assembly of F-actin contribute to 






Figure 4.21 Drp1- and F-actin- containing mitochondrial tubule formation in 
Usp30CS-expressing cells upon FCCP treatment. HeLa cells cotransfected with 
Usp30CS, YFP-Drp1 (green on overlay images) and mRuby-Lifeact (red on overlay 
images), treated with FCCP, followed by time-lapse structured illumination 






Section 4: Discussion 
            In this chapter, I presented data supporting the possibility that Usp30, an 
OMM anchored DUB, contributes to the control of Drp1-mediated mitochondrial 
division. I found that Usp30 inhibition in Usp30-/- HCT116 cells and HeLa cells 
expressing Usp30CS mutant resulted in extensive mitochondrial tubulation. The BN-
PAGE, crosslinking and superresolution imaging support the possibility that Usp30 
activity is required for the late stage of Drp1-mediated mitochondrial fission, perhaps 
the remodeling of the oligomeric fission complexes. Furthermore, I found that 
mitochondrial-associated F-actin was stabilized in cells expressing Usp30CS, 
suggesting that Usp30 activity also controls mitochondrial fission-dependent transient 
F-actin polymerization on the OMM.  
            Recently, Chen and colleagues proposed a novel mechanism by which Usp30 
could regulate mitochondrial dynamics (Yue et al. 2014). They showed that, Usp30 
physically interacted with Mfns and thereby reduced ubiquitination of Mfn1 and 
Mfn2, whereas Usp30CS did not affect ubiquitination levels of Mfns. Consistent with 
this report, I also found that Usp30CS expression induced interconnected mitochondria. 
However, rather than regulating Mfns, we found that Usp30 interacted with Drp1 and 
controlled the oligomeric status of Drp1 on the mitochondria. However, we were not 
able to observe any difference in Drp1 protein expression in Usp30WT- and USP30CS-
Figure 4.22 Drp1- and F-actin- containing mitochondrial tubule formation in 
Usp30CS-expressing cells upon FCCP treatment (continued). HeLa cells 
cotransfected with Usp30CS, YFP-Drp1 (green on overlay images) and mRuby-
Lifeact (red on overlay images), treated with FCCP, followed by time-lapse 
structured illumination microscopy. Higher magnifications of areas marked with 
rectangles are shown in detail images. 
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expressing cells, indicating that Usp30 does not regulate Drp1 degradation, but rather 
the activity of Drp1. Thus, Usp30 may serve as a multi-target OMM deubiquitinase 
that modifies the function of mitochondrial fusion and fission proteins without 
affecting their stability. 
            Interestingly, mitochondrial changes observed in cells expressing higher 
levels of Usp30CS were highly reminiscent of the mitochondrial alterations induced 
by overexpression of recently identified mitochondrial Drp1 receptor MiD49/51. 
Therefore it is likely that Usp30 controls MiD49/51 proteins. Studies addressing this 
possibility are currently being conducted in the Karbowski lab.  
FCCP-induced transient F-actin assembly on the OMM appears to be a 
required step that contributes to Drp1-dependent mitochondrial fission. Mitochondrial 
F-actin polymerization acts as a parallel event to Drp1 assembly and likely influence 
Drp1-driven membrane constriction and scission. Following Usp30CS expression, we 
found that actin filaments assemble on mitochondria tubules in synchrony with Drp1 
translocation from the cytosol to the mitochondria upon FCCP treatment. As FCCP-
induced actin nucleation is independent of Drp1, it is likely that F-actin 
polymerization in Usp30CS-expressing cells occurs in a similar timeframe to, but is 
not coupled to Drp1 recruitment. The independence of mitochondrial F-actin 
assembly from Drp1 recruitment points to a role for Usp30 in regulating the F-actin-
dependent step of mitochondrial fission. Alternatively, given that actin filaments 
disassembly is dependent on Drp1 GTPase activity, the accumulation of 
mitochondrial F-actin may also be a consequence of the inhibition of the Drp1-
mediated membrane scission event. 
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Chapter 5:  Summaries 
 
             In summary, I reported a novel mechanism by which F-actin controls Drp1-
dependent mitochondrial fission. I found that F-actin assembled on the OMM upon 
stress (FCCP and AntA)-induced and mitotic mitochondrial fission. Mitochondrial 
disassembly of F-actin upon FCCP/AntA treatments was delayed in cells deficient in 
mitochondrial fission (Drp1-/- and Mff-/- MEFs), as compared to wild type MEFs. 
Furthermore, actin polymerization inhibitor LatB inhibited mitochondrial toxin-
induced mitochondrial fission, suggesting that de novo F-actin polymerization is 
required for mitochondrial fission. Mitochondria-associated F-actin colocalized with 
the OMM marker Tom20, rather than with cytochrome c labeled IMM and IMS, 
suggesting that F-actin localized to the OMM and did not specifically localize on the 
mitochondrial constriction sites. Furthermore, I showed that rather than linear actin 
filaments, Arp2/3 complex-mediated branched F-actin nucleator, as well as other 
related factors, including cortactin and cofilin, controlled F-actin dependent 
mitochondrial fission. Moreover, I also discovered that Usp30, a mitochondrial 
membrane anchored deubiqutinase-dependent control of mitochondrial fission 
involved mitochondrial assembly of F-actin. In conclusion, this study reveals a novel 
mechanism of transient F-actin assembly on mitochondria that contributes to Drp1-
mediated mitochondrial fission.  
Based on these data, we propose a working model of how F-actin could 
participate in mitochondrial fission. Upon stress-induced or mitotic mitochondrial 
fission, G-actin molecules assemble into F-actin on the OMM in a Drp1-independent 
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manner. The assembly of mitochondrial associated F-actin is initiated by Arp2/3 
complex, a class II nucleating promoting factor cortactin and actin severing factor 
cofilin. Under this model, Drp1 can be recruited from the cytosol to the mitochondria 
in an actin-independent manner. Therefore, mitochondrial actin polymerization and 
Drp1 recruitment act as two parallel events, which are both, required for the 
completion of mitochondrial fission. Either the disassociation of mitochondrial actin 
or Drp1 containing fission complex activity requires the activity of each other. In the 
absence of mitochondrial assembly of F-actin, Drp-1 mediated mitochondrial fission 
can not be completed, resulting in increasing mitochondrial, accumulation of Drp1, 
whereas loss of functional Drp1 results in accumulation of mitochondrial F-actin 
accompanied by reduced mitochondrial fission activity. 
Since Drp1 translocation and F-actin polymerization did not correlate with 
each other temporally, the functional and molecular relationship between Drp1 and 
OMM-associated F-actin needs to be further investigated. As revealed by in vitro 
studies, dynamin (a founding member of dynamin protein family) can interact with 
actin cytoskeleton and align F-actin into bundles (Gu et al. 2010b). It is necessary to 
examine the degree to which Drp1, a dynamin family member, mediates 
mitochondrial fission through interacting with OMM-associated F-actin. 
Mitochondrial Drp1 receptors such as Mff, Fis1 and MiD49/51 may also control the 
assembly of F-actin on the OMM and thereby contribute to F-actin-dependent 
mitochondrial membrane remodeling during mitochondrial fission.  
Mitochondrial fission occurs through the membrane constriction and scission 
by Drp1 assembly-dependent GTP hydrolysis (Ingerman et al. 2005). One possible 
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mechanism is that mitochondrial F-actin provides the mechanical force that 
contributes to membrane constriction at membrane curvature. While myosin II was 
reported to assist mitochondrial fission (Korobova et al. 2014b), it is possible that 
mitochondrial F-actin associates with myosin II to provide membrane tension force to 
promote mitochondrial membrane constriction and help position Drp1 at 
mitochondrial constriction sites. 
The factors controlling initiation of F-actin polymerization on the OMM 
during mitochondrial fission are also unknown. It has been reported that during 
clathrin-mediated endocytosis BAR domain superfamily proteins are recruited to 
invaginated buds to sense membrane curvature by preferentially binding to highly 
curved membranes (Ferguson et al. 2009). Given that a cytosolic BAR domain 
protein endophilin B1 (Bif-1) can associate with the mitochondria (Karbowski, Jeong, 
et al. 2004), it is appealing to explore the role of endophilin B1 and other BAR 
domain proteins in initiation of F-actin polymerization on the OMM during 
mitochondrial fission. In addition, phosphoinositide lipids promote Arp2/3 mediated 
F-actin polymerization by binding to nucleating promoting factors WASP and inhibit 
actin capping protein cofilin and G-actin binding protein profilin (Bezanilla et al. 
2015). Mitochondrial assembly of F-actin network may also be regulated by 
membrane phosphoinositides by regulating actin-modifying proteins activity.  
My work showed that a transient branched F-actin polymerization initiated by 
Arp2/3 complex is vital for mitochondrial fission. The role of branched F-actin 
polymerization has been established in membrane remodeling during clathrin-
mediated endocytosis (Mooren et al. 2012). Meanwhile, INF2 promotes Drp1-
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dependent mitochondrial fission by modifying linear F-actin network that was 
suggested to assemble at the mitochondrial constriction sites along with the ER-
mitochondria contact sites (Korobova et al. 2013). However, INF2 was not found to 
affect stress-induced mitochondrial fission (see Chapter 3). Thus, it is critical to 
clarify the mechanism by which linear and branched F-actin network co-regulate 
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